Prof. J. Booij PhD publications

2021

• Kazmi Hiba, Walker Zuzana, Booij Jan, Khan Faraan, Shah Sachit, Sudre Carole H., Buckman Joshua E. J., Schrag Anette-Eleonore Late onset depression: Dopaminergic deficit and clinical features of prodromal Parkinson's disease: A cross-sectional study Journal of neurology, neurosurgery, and psychiatry 2021;92 (2):158-164 [PubMed]
• Schalbroeck Rik, van Velden Floris H. P., de Geus-Oei Lioe-Fee, Yaqub Maqsood, van Amelsvoort Therese, Booij Jan, Selten Jean-Paul Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [18F]-FDOPA PET/CT study Translational psychiatry 2021;11 (1) [PubMed]

2020

• Schneider Maude, Vaessen Thomas, van Duin Esther D. A., Kasanova Zuzana, Viechtbauer Wolfgang, Reininghaus Ulrich, Vingerhoets Claudia, Booij Jan, Swillen Ann, Vorstman Jacob A. S., van Amelsvoort Thérèse, Myin-Germeys Inez Affective and psychotic reactivity to daily-life stress in adults with 22q11DS: a study using the experience sampling method Journal of neurodevelopmental disorders 2020;12 (1) [PubMed]
• van Deursen Dagmar N., van den Heuvel Odile A., Booij Jan, Berendse Henk W., Vriend Chris Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies Journal of neurology 2020;267 (7):1922-1930 [PubMed]
• Gumbs Myrtille C. R. Brain circuitries in control of feeding behaviors: Focus on Neuropeptide Y 2020. 282p. ISBN 9789402818789. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij Jan, la Fleur Susanne E.; Co-supervisor: Mul J. D.)
• Di Censo Rita, Abdelnour Carla, Blanc Frederic, Bousiges Olivier, Lemstra Afina W., Van Steenoven Inger, Onofrj Marco, Aarsland Dag, Bonanni Laura, Study group members AMC , Geurtsen Gerrit, Booij Jan CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies Journal of neurology, neurosurgery, and psychiatry 2020;91 (1):109-110 [PubMed]
• Thomas Jana, Ooms Sharon J., Mentink Lara J., Booij Jan, Olde Rikkert Marcel G. M., Overeem Sebastiaan, Kessels Roy P. C., Claassen Jurgen A. H. R. Effects of long-term sleep disruption on cognitive function and brain amyloid-β burden: a case-control study ALZHEIMERS RESEARCH & THERAPY 2020;12 (1):101 [PubMed]
• Cybulska Klaudia, Perk Lars, Booij Jan, Laverman Peter, Rijpkema Mark Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers Molecules 2020;25 (3) [PubMed]
• Hartstra Annick V., Schüppel Valentina, Imangaliyev Sultan, Schrantee Anouk, Prodan Andrei, Collard Didier, Levin Evgeni, Dallinga-Thie Geesje, Ackermans Mariette T., Winkelmeijer Maaike, Havik Stefan R., Metwaly Amira, Lagkouvardos Ilias, Nier Anika, Bergheim Ina, Heikenwalder Mathias, Dunkel Andreas, Nederveen Aart J., Liebisch Gerhard, Mancano Giulia, Claus Sandrine P., Benítez-Páez Alfonso, la Fleur Susanne E., Bergman Jacques J., Gerdes Victor, Sanz Yolanda, Booij Jan, Kemper Elles, Groen Albert K., Serlie Mireille J., Haller Dirk, Nieuwdorp Max Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome Molecular metabolism 2020;42 [PubMed]
• Booij Jan, Eshuis Silvia, Meijer A., Berendse H. Regionale (mede)beoordeling van nucleaire onderzoeken bij patiënten met parkinsonisme: is de tijd er rijp voor?: Translationeel onderzoek ten bate van hersenonderzoek binnen de nucleaire geneeskunde Tijdschrift voor nucleaire geneeskunde 2020:2562
• van der Pluijm Marieke, Cassidy Clifford, Zandstra Melissa, Wallert Elon, de Bruin Kora, Booij Jan, de Haan Lieuwe, Horga Guillermo, van de Giessen Elsmarieke Reliability and Reproducibility of Neuromelanin-Sensitive Imaging of the Substantia Nigra: A Comparison of Three Different Sequences Journal of magnetic resonance imaging 2020 [PubMed]
• van der Zande J. J., Joling M., Happach I. G., Vriend C., Scheltens Ph., Booij J., Lemstra A. W. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study NeuroImage. Clinical 2020;25 [PubMed]
• Zoons Evelien, Tijssen Marina A. J., Dreissen Yasmine E. M., Smit Marenka, Booij Jan The effect of escitalopram on central serotonergic and dopaminergic systems in patients with cervical dystonia, and its relationship with clinical treatment effects: A double-blind placebo- controlled trial Biomolecules 2020;10 (6) [PubMed]
• Boertien Tessel M., Drent Madeleine L., Booij Jan, Majoie Charles B. L. M., Stokkel Marcel P. M., Hoogmoed Jantien, Pereira Alberto, Biermasz Nienke R., Simsek Suat, Groote Veldman Ronald, Tanck Michael W. T., Fliers Eric, Bisschop Peter H. The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga -DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lan reotide on t umour size BMJ open 2020;10 (8):e038250 [PubMed]
• Bakker Geor, Vingerhoets Claudia, Bloemen Oswald J. N., Sahakian Barbara J., Booij Jan, Caan Matthan W. A., van Amelsvoort Thérèse A. M. J. The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders NeuroImage. Clinical 2020;27 [PubMed]
• Suwijn Sven R., Samim Hamdia, Eggers Carsten, Espay Alberto J., Fox Susan, Lang Anthony E., Samuel Mike, Silverdale Monty, Verschuur Constant V. M., DIjk Joke M., Verberne Hein J., Booij Jan, de Bie Rob M. A. Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD) Journal of Parkinson s disease 2020;10 (4):1561-1569 [PubMed]
• Fritz Daan, van de Beek Diederik, Brouwer Matthijs C., Booij Jan Whole-Body 18F-FDG PET-CT in the Diagnosis of Neurosarcoidosis Mayo Clinic proceedings. Mayo Clinic 2020;95 (5):1082-1084

2019

• Arnaldi Dario, Meles Sanne K., Giuliani Alessandro, Morbelli Silvia, Renken Remco J., Janzen Annette, Sittig-Wiegand Elisabeth, Depboylu Candan, Reetz Kathrin, Overeem Sebastiaan, Pijpers Angelique, Reesink Fransje E., van Laar Teus, Teune Laura K., Höffken Helmut, Luster Marcus, Timmermann Lars, Kesper Karl, Adriaanse Sofie M., Booij Jan, Sambuceti Gianmario, Girtler Nicola Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease Journal of Parkinson s disease 2019;9 (1):229-239 [PubMed]
• Schrantee Anouk, Solleveld Michelle M., Schwantje Hilde, Bruin Willem B., Mutsaerts Henk-Jan M. M., Adriaanse Sofie M., Lucassen Paul, Booij Jan, Reneman Liesbeth Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study Journal of psychopharmacology (Oxford, England) 2019;33 (6):660-669 [PubMed]
• Jansen Bernard H. E., Kramer Gem M., Cysouw Matthijs C. F., Yaqub Maqsood M., de Keizer Bart, Lavalaye Jules, Booij Jan, Vargas Hebert Alberto, Morris Michael J., Vis André N., van Moorselaar Reindert J. A., Hoekstra Otto S., Boellaard Ronald, Oprea-Lager Daniela E. Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone Journal of nuclear medicine 2019;60 (8):1111-1117 [PubMed]
• Shalgunov Vladimir, van Waarde Aren, Booij Jan, Michel Martin C., Dierckx Rudi A. J. O., Elsinga Philip H. Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging Medicinal Research Reviews 2019;39 (3):1014-1052 [PubMed]
• Vingerhoets Claudia, Bakker Geor, Schrantee Anouk, van der Pluijm Marieke, Bloemen Oswald J. N., Reneman Liesbeth, Caan Matthan, Booij Jan, van Amelsvoort Therese A. M. J. Influence of muscarinic M1 receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study PSYCHIATRY RESEARCH-NEUROIMAGING 2019;290:5-13 [PubMed]
• van Duin Esther D. A., Ceccarini Jenny, Booij Jan, Kasanova Zuzana, Vingerhoets Claudia, van Huijstee Jytte, Heinzel Alexander, Mohammadkhani-Shali Siamak, Winz Oliver, Mottaghy Felix, Myin-Germeys Inez, van Amelsvoort Thérèse Lower [ 18 F]fallypride binding to dopamine D 2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: A positron emission tomography study Psychological medicine 2019;50 (5):799-807 [PubMed]
• van Duin Esther D. A., Vaessen Thomas, Kasanova Zuzana, Viechtbauer Wolfgang, Reininghaus Ulrich, Saalbrink Peter, Vingerhoets Claudia, Hernaus Dennis, Booij Jan, Swillen Ann, Vorstman Jacob, van Amelsvoort Thérèse, Myin-Germeys Inez Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome Psychoneuroendocrinology 2019;106:85-94 [PubMed]
• Vingerhoets Claudia, van Oudenaren Mathilde J F, Bloemen Oswald J N, Boot Erik, van Duin Esther D A, Evers Laurens J M, Fiksinski Ania M, Breetvelt Elemi J, Palmer Lisa D, Vergaelen Elfi, Vogels Annick, Meijer Carin, Booij Jan, de Haan Liewe, Swillen Ann, Vorstman Jacob A S, Bassett Anne S, van Amelsvoort Therese A M J Low prevalence of substance use in people with 22q11.2 deletion syndrome British journal of psychiatry 2019;215 (5):661-667 [PubMed]
• van der Pluijm Marieke, Sutterland Arjen L, van Kuilenburg André B P, Zoetekouw Lida, de Haan Lieuwe, Booij Jan, van de Giessen Elsmarieke Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients Therapeutic advances in psychopharmacology 2019;9 [PubMed]
• Suwijn Sven R., Verschuur Constant V. M., Slim Marleen A., Booij Jan, de Bie Rob M. A. Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease EJNMMI research 2019;9 (1) [PubMed]
• Thomas Jana, Ooms Sharon, Verbeek Marcel, Booij Jan, Rijpkema Mark, Kessels Roy P. C., Overeem Sebastiaan, Claassen Jurgen Sleep-Cognition Hypothesis in maritime Pilots, what is the effect of long-term work-related poor sleep on cognition and amyloid accumulation in healthy middle-aged maritime pilots: Methodology of a case-control study BMJ open 2019;9 (6) [PubMed]
• Joling Merijn, Vriend Chris, Raijmakers Pieter G H M, van der Zande Jessica J, Lemstra Afina W, Berendse Henk W, Booij Jan, van den Heuvel Odile A Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study NeuroImage. Clinical 2019;22:101755 [PubMed]

2018

• Ahmed Anwar, Huang Juebin, Chen Kun, Zubeldia José M., Booij Jan, Vijayakumar Vani [123I]Ioflupane imaging in Caucasians and non-Caucasians: Are there any differences? Journal of the neurological sciences 2018;395:159-163 [PubMed]
• Adriaanse Sofie M., de Wit Tim C., Stam Mette, Verwer Eline, de Bruin Kora M., Booij Jan Clinical evaluation of [123I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison EJNMMI research 2018;8 [PubMed]
• Kasanova Zuzana, Ceccarini Jenny, Frank Michael J., van Amelsvoort Thérèse, Booij Jan, Heinzel Alexander, Mottaghy Felix M., Myin-Germeys Inez Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis European neuropsychopharmacology 2018;28 (12):1314-1324
• Vingerhoets Claudia, Bloemen Oswald J. N., Boot Erik, Bakker Geor, de Koning Mariken B., da Silva Alves Fabiana, Booij Jan, van Amelsvoort Thérèse A. M. J. Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis PSYCHIATRY RESEARCH-NEUROIMAGING 2018;272:65-70 [PubMed]
• Booij Jan, Adriaanse S. M., Reneman Liesbeth, de Bie Rob M. A. Dopaminetransporterscintigrafie bij patiënten met parkinsonisme IMAGO 2018 (2):37-42
• Heinen Charlotte A., Zhang Zhi, Klieverik Lars P., de Wit Tim C., Poel Edwin, Yaqub Maqsood, Boelen Anita, Kalsbeek Andries, Bisschop Peter H., van Trotsenburg A. S. Paul, Verberne Hein J., Booij Jan, Fliers Eric Effects of intravenous thyrotropin-releasing hormone on18F-fluorodeoxyglucose uptake in human brown adipose tissue: a randomized controlled trial European journal of endocrinology / European Federation of Endocrine Societies 2018;179 (1):31-38 [PubMed]
• Kasanova Zuzana, Ceccarini Jenny, Frank Michael J., van Amelsvoort Thérèse, Booij Jan, van Duin Esther, Steinhart Henrietta, Vaessen Thomas, Heinzel Alexander, Mottaghy Felix, Myin-Germeys Inez Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder Psychological medicine 2018;48 (11):1909-1914 [PubMed]
• Joling Merijn, Vriend Chris, van der Zande Jessica J., Lemstra Afina W., van den Heuvel Odile A., Booij Jan, Berendse Henk W. Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies NeuroImage. Clinical 2018;19:130-136 [PubMed]
• Stam M. K., Verwer E. E., Booij J., Adriaanse S. M., de Bruin C. M., de Wit T. C. Performance evaluation of a novel brain-dedicated SPECT system EJNMMI physics 2018;5 (1):4 [PubMed]
• Zoons Evelien, Booij Jan, Delnooz Catherine C. S., Dijk Joke M., Dreissen Yasmine E. M., Koelman Johannes H. T. M., van der Salm Sandra M. A., Skorvanek Matej, Smit Marenka, Aramideh Majid, Bienfait Henriette, Boon Agnita J. W., Brans Jeroen W. M., Hoogerwaard Edo, Hovestadt Ad, Kamphuis Daan J., Munts Alexander G., Speelman Johannes D., Tijssen Marina A. J. Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor Journal of neurology, neurosurgery, and psychiatry 2018;89 (6):579-585 [PubMed]
• Bakker Geor, Vingerhoets Claudia, Boucherie Daphne, Caan Matthan, Bloemen Oswald, Eersels Jos, Booij Jan, van Amelsvoort Thérèse Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis NeuroImage. Clinical 2018;18:713-719 [PubMed]
• Smit Marenka, García David V. llez, de Jong Bauke M., Zoons Evelien, Booij Jan, Dierckx Rudi A., Willemsen Antoon T., de Vries Erik F., Bartels Anna L., Tijssen Marina A. Relationships between serotonin transporter binding in the raphe nuclei, basal ganglia, and hippocampus with clinical symptoms in cervical dystonia: A [11C]DASB positron emission tomography study Frontiers in neurology 2018;9 (FEB) [PubMed]
• Joling Merijn, van den Heuvel Odile A., Berendse Henk W., Booij Jan, Vriend Chris Serotonin transporter binding and anxiety symptoms in Parkinson's disease Journal of neurology, neurosurgery, and psychiatry 2018;89 (1):89-94 [PubMed]
• Schrantee Anouk, Lucassen Paul J., Booij Jan, Reneman Liesbeth Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity European neuropsychopharmacology 2018;28 (10):1173-1179 [PubMed]
• ter Horst Kasper W., Lammers Nicolette M., Trinko Richard, Opland Darren M., Figee Martijn, Ackermans Mariette T., Booij Jan, Munckhof Pepijn van den, Schuurman P. Richard, Fliers Eric, Denys Damiaan, DiLeone Ralph J., la Fleur Susanne E., Serlie Mireille J. Striatal dopamine regulates systemic glucose metabolism in humans and mice Science translational medicine 2018;10 (442) [PubMed]
• van Duin Esther D. A., Kasanova Zuzana, Hernaus Dennis, Ceccarini Jenny, Heinzel Alexander, Mottaghy Felix, Mohammadkhani-Shali Siamak, Winz Oliver, Frank Michael, Beck Merrit C. H., Booij Jan, Myin-Germeys Inez, van Amelsvoort Thérèse Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome European neuropsychopharmacology 2018;28 (6):732-742 [PubMed]
• Meles Sanne K., Renken Remco J., Janzen Annette, Vadasz David, Pagani Marco, Arnaldi Dario, Morbelli Silvia, Nobili Flavio, Mayer Geert, Leenders Klaus L., Oertel Wolfgang H., Sittig-Wiegand Elisabeth, Depboylu Candan, Reetz Kathrin, Overeem Sebastiaan, Pijpers Angelique, Reesink Fransje E., van Laar Teus, Teune Laura K., Höffken Helmut, Luster Marcus, Timmermann Lars, Kesper Karl, Adriaanse Sofie M., Booij Jan, Sambuceti Gianmario, Girtler Nicola, Jonsson Cathrine The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease Journal of nuclear medicine 2018;59 (9):1437-1444 [PubMed]
• van Galen Katy A., ter Horst Kasper W., Booij Jan, la Fleur Susanne E., Serlie Mireille J. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies Metabolism: clinical and experimental 2018;85:325-339 [PubMed]
• Zoons Evelien The role of dopamine and serotonin in cervical dystonia 2018. 169p. ISBN 9789462998490. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Koning-Tijssen M. A. J., Booij J.)
• Boot Erik, Butcher Nancy J, Udow Sean, Marras Connie, Mok Kin Y, Kaneko Satoshi, Barrett Matthew J, Prontera Paolo, Berman Brian D, Masellis Mario, Dufournet Boris, Nguyen Karine, Charles Perrine, Mutez Eugénie, Danaila Teodor, Jacquette Aurélia, Colin Olivier, Drapier Sophie, Borg Michel, Fiksinski Ania M, Vergaelen Elfi, Swillen Ann, Vogels Annick, Plate Annika, Perandones Claudia, Gasser Thomas, Clerinx Kristien, Bourdain Frédéric, Mills Kelly, Williams Nigel M, Wood Nicholas W, Booij Jan, Lang Anthony E, Bassett Anne S Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2 Neurology 2018;90 (23):e2059-e2067 [PubMed]

2017

• Tossici-Bolt Livia, Dickson John C., Sera Terez, Booij Jan, Asenbaun-Nan Susanne, Bagnara Maria C., Borght Thierry Vander, Jonsson Cathrine, de Nijs Robin, Hesse Swen, Koulibaly Pierre M., Akdemir Umit O., Koole Michel, Tatsch Klaus, Varrone Andrea [(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods EJNMMI physics 2017;4 (1):8 [PubMed]
• Bahler Lonneke, Holleman Frits, Chan Man-Wai, Booij Jan, Hoekstra Joost B., Verberne Hein J. 18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure PLoS ONE 2017;12 (5):e0176242 [PubMed]
• Joling Merijn, Vriend Chris, van den Heuvel Odile A., Raijmakers Pieter G. H. M., Jones Paul A., Berendse Henk W., Booij Jan Analysis of Extrastriatal I-123-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases Journal of nuclear medicine 2017;58 (7):1117-1123 [PubMed]
• Selten Jean-Paul, Booij Jan, Buwalda Bauke, Meyer-Lindenberg Andreas Biological Mechanisms Whereby Social Exclusion May Contribute to the Etiology of Psychosis: A Narrative Review Schizophrenia bulletin 2017;43 (2):287-292 [PubMed]
• Boot E., Hollak C. E. M., Huijbregts S. C. J., Jahja R., van Vliet D., Nederveen A. J., Nieman D. H., Bosch A. M., Bour L. J., Bakermans A. J., Abeling N. G. G. M., Bassett A. S., van Amelsvoort T. A. M. J., van Spronsen F. J., Booij J. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria Psychological medicine 2017;47 (16):2854-2865 [PubMed]
• Doppler Kathrin, Jentschke Hanna-Maria, Schulmeyer Lena, Vadasz David, Janzen Annette, Luster Markus, Höffken Helmut, Mayer Geert, Brumberg Joachim, Booij Jan, Musacchio Thomas, Klebe Stephan, Sittig-Wiegand Elisabeth, Volkmann Jens, Sommer Claudia, Oertel Wolfgang H. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease Acta neuropathologica 2017;133 (4):535-545 [PubMed]
• Shalgunov Vladimir Development of 18F-labeled agonist radioligands for the imaging of the high-affinity state of dopamine D2/3 receptors in the central nervous system by positron emission tomography (PET) 2017. 282p. [UvA Dissertations Online] University of Groningen: Department of Nuclear Medicine and Molecular Imaging. (Supervisors: Elsinga P. H., Booij J.; Co-supervisor: Dierckx R. A. J. O.)
• Booij Jan, Dubroff Jacob, Pryma Daniel, Yu Jian, Agarwal Rajan, Lakhani Paras, Kuo Phillip H. Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia Journal of nuclear medicine 2017;58 (11):1821-1826 [PubMed]
• Bahler L., Verberne H. J., Soeters M. R., Booij J., Hoekstra J. B., Holleman F. Dopaminergic Effects on Brown Adipose Tissue (DEBAT): A prospective physiological study Diabetes & metabolism 2017;43 (2):172-175 [PubMed]
• Meles Sanne K., Vadasz David, Renken Remco J., Sittig-Wiegand Elisabeth, Mayer Geert, Depboylu Candan, Reetz Kathrin, Overeem Sebastiaan, Pijpers Angelique, Reesink Fransje E., van Laar Teus, Heinen Lisette, Teune Laura K., Höffken Helmut, Luster Marcus, Kesper Karl, Adriaanse Sofie M., Booij Jan, Leenders Klaus L., Oertel Wolfgang H. FDG PET, Dopamine Transporter SPECT, and Olfaction: Combining Biomarkers in REM Sleep Behavior Disorder Movement disorders 2017;32 (10):1482-1486 [PubMed]
• Bahler Lonneke, Holleman Frits, Booij Jan, Hoekstra Joost B., Verberne Hein J. Hot heads & cool bodies: The conundrums of human brown adipose tissue (BAT) activity research European journal of internal medicine 2017;40:26-29 [PubMed]
• Bakker Geor Innovative Approaches to Understanding the Neurobiology of Psychosis 2017. 137p. [UvA Dissertations Online] University Maastricht: Department of Psychiatry & Psychology. (Supervisors: Booij J., van Amelsvoort T. A. M. J.; Co-supervisors: Caan M. W. A., Bloemen O. J. N.)
• Vingerhoets Wilhelmina Antonia Maria Investigating neurobiological mechanisms underlying comorbid cognitive symptoms in psychosis and substance use 2017. 221p. ISBN 9789462995529. [UvA Dissertations Online] Maastricht University: Faculty of Health, Medicine and Life Sciences. (Supervisors: Booij J., Bloemen O. J. N.; Co-supervisor: Oswald J. N.)
• Bähler Lonneke Keep cool and stay lean 2017. 214p. ISBN 9789462335356. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij J., Hoekstra J. B. L.; Co-supervisors: Holleman F., Verberne H. J.)
• Zoons E., Booij J., Speelman J. D., Dreissen Y. E. M., Smit M., Tijssen M. A. J. Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms EJNMMI research 2017;7 (1):87 [PubMed]
• Hakimzadeh Nazanin, Pinas Victorine A., Molenaar Ger, de Waard Vivian, Lutgens Esther, van Eck-Smit Berthe L. F., de Bruin Kora, Piek Jan J., Eersels Jos L. H., Booij Jan, Verberne Hein J., Windhorst Albert D. Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques PLoS ONE 2017;12 (11) [PubMed]
• Schrantee Anouk, Václavů Lena, Reneman Liesbeth, Verberne Hein J., Booij Jan, Tan Hanno L. QT prolongation by dexamphetamine: Does experience matter? Journal of cardiovascular electrophysiology 2017;28 (8):912-916 [PubMed]
• Schrantee Anouk, Tremoleda Jordi L., Wylezinska-Arridge Marzena, Bouet Valentine, Hesseling Peter, Meerhoff Gideon F., de Bruin Kora M., Koeleman Jan, Freret Thomas, Boulouard Michel, Desfosses Emilie, Galineau Laurent, Gozzi Alessandro, Dauphin François, Gsell Willy, Booij Jan, Lucassen Paul J., Reneman Liesbeth Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate PLoS ONE 2017;12 (2):e0172776 [PubMed]
• Versteeg Ruth I., Koopman Karin E., Booij Jan, Ackermans Mariëtte T., Unmehopa Unga A., Fliers Eric, la Fleur Susanne E., Serlie Mireille J. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans Neuroendocrinology 2017;105 (2):141-149 [PubMed]
• Kasanova Zuzana, Ceccarini Jenny, Frank Michael J., van Amelsvoort Thérèse, Booij Jan, Heinzel Alexander, Mottaghy Felix, Myin-Germeys Inez Striatal dopaminergic modulation of reinforcement learning predicts reward-oriented behavior in daily life Biological psychology 2017;127:1-9 [PubMed]
• Vingerhoets Claudia, Bakker Geor, van Dijk Jelske, Bloemen Oswald J. N., Wang Ya, Chan Raymond C. K., Booij Jan, van Amelsvoort Therese A. M. J. The effect of the muscarinic M-1 receptor antagonist biperiden on cognition in medication free subjects with psychosis European neuropsychopharmacology 2017;27 (9):854-864 [PubMed]
• Dickson John C., Tossici-Bolt Livia, Sera Terez, Booij Jan, Ziebell Morten, Morbelli Silvia, Assenbaum-Nan Susanne, Borght Thierry Vander, Pagani Marco, Kapucu Ozlem L., Hesse Swen, van Laere Koen, Darcourt Jacques, Varrone Andrea, Tatsch Klaus The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging EJNMMI research 2017;7 (1):10 [PubMed]
• Morbelli Silvia, Arbizu Javier, Booij Jan, Chen Ming-Kai, Chetelat Gael, Cross Donna J., Djekidel Mehdi, Drzezga Alexander, Ekmekcioglu Ozgul, Garibotto Valentina, Hesse Swen, Ishii Kazunari, Jafari Lida, Lammertsma Adriaan A., Law Ian, Mathews Dana, Minoshima Satoshi, Mosci Karina, Pagani Marco, Pappata Sabina, Silverman Daniel Hillel, Signore Alberto, van de Giessen Elsmarieke, Villemagne Victor, Barthel Henryk The need of standardization and of large clinical studies in an emerging indication of [18 F] FDG PET: the autoimmune encephalitis (vol 44, pg 353, 2017) European journal of nuclear medicine and molecular imaging 2017;44 (3):559-560 [PubMed]
• Morbelli Silvia, Arbizu Javier, Booij Jan, Chen Ming-Kai, Chetelat Gael, Cross Donna J., Djekidel Mehdi, Drzezga Alexander, Ekmekcioglu Ozgul, Garibotto Valentina, Hesse Swen, Ishii Kazunari, Saraf Lida Jafari, Lammertsma Adriaan A., Law Ian, Mathews Dana, Minoshima Satoshi, Mosci Karina, Pagani Marco, Pappata Sabina, Silverman Daniel Hillel, Signore Alberto, van de Giessen Elsmarieke, Villemagne Victor, Barthel Henryk The need of standardization and of large clinical studies in an emerging indication of [F-18]FDG PET: the autoimmune encephalitis European journal of nuclear medicine and molecular imaging 2017;44 (3):353-357 [PubMed]
• Zoons E., Tijssen M. A. J., Dreissen Y. E. M., Speelman J. D., Smit M., Booij J. The relationship between the dopaminergic system and depressive symptoms in cervical dystonia European journal of nuclear medicine and molecular imaging 2017;44 (8):1375-1382 [PubMed]
• Versteeg Ruth I., Schrantee Anouk, Adriaanse Sofie M., Unmehopa Unga A., Booij Jan, Reneman Liesbeth, Fliers Eric, la Fleur Susanne E., Serlie Mireille J. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding FASEB journal 2017;31 (10):4545-4554 [PubMed]

2016

• van der Zande J. J., Booij J., Scheltens P., Raijmakers P. G. H. M., Lemstra A. W. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies European journal of nuclear medicine and molecular imaging 2016;43 (6):1060-1066 [PubMed]
• Zaaijer Eline, Goudriaan Anna E., Koeter Maarten W. J., Booij Jan, van den Brink Wim Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands Substance use & misuse 2016;51 (14):1905-1911 [PubMed]
• Koopman K. E., Roefs A., Elbers D. C. E., Fliers E., Booij J., Serlie M. J., La Fleur S. E. Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men Psychological medicine 2016;46 (8):1707-1717 [PubMed]
• Bahler L., Verberne H. J., Brakema E., Tepaske R., Booij J., Hoekstra J. B., Holleman F. Bromocriptine and insulin sensitivity in lean and obese subjects Endocrine connections 2016;5 (6):44-52 [PubMed]
• Verschure Derk O., Boot Erik, van Amelsvoort Thérèse A., Booij Jan, van Eck-Smit Berthe L. F., Somsen G. Aernout, Verberne Hein J. Cardiac sympathetic activity in 22q11.2 deletion syndrome International journal of cardiology 2016;212:346-351 [PubMed]
• Verschure Derk O., Boot Erik, van Amelsvoort Thérèse A., Booij Jan, van Eck-Smit B. L. F., Somsen G. Aernout, Verberne Hein J. Corrigendum to "Cardiac sympathetic activity in 22q11.2 deletion syndrome" [Int. J. Cardiol. 212 (2016) 346-351] International journal of cardiology 2016;222:1141 [PubMed]
• Bakker Geor, Caan Matthan W. A., Vingerhoets Wilhelmina A. M., da Silva-Alves Fabiana, de Koning Mariken, Boot Erik, Nieman Dorien H., de Haan Lieuwe, Bloemen Oswald J., Booij Jan, van Amelsvoort Thérèse A. M. J. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome PLoS ONE 2016;11 (11):e0159928 [PubMed]
• Bakker G., Caan M. W. A., Schluter R. S., Bloemen O. J. N., da Silva-Alves F., de Koning M. B., Boot E., Vingerhoets W. A. M., Nieman D. H., de Haan L., Booij J., van Amelsvoort T. A. M. J. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis Psychological medicine 2016;46 (11):2299-2311 [PubMed]
• Schrantee Anouk, Ferguson Bart, Stoffers Diederick, Booij Jan, Rombouts Serge, Reneman Liesbeth Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain imaging and behavior 2016;10 (2):548-558 [PubMed]
• Cheung Z. J. , Oerlemans S. H., Booij J. Focal radiotracer uptake below the bladder in bone scintigraphy is related to the volume of tissue removed by transurethral resection of the prostate (TURP) in patients with known prostate malignancy Tijdschrift voor nucleaire geneeskunde 2016;38 (1):1525-1527
• Albert Nathalie L., Unterrainer Marcus, Diemling Markus, Xiong Guoming, Bartenstein Peter, Koch Walter, Varrone Andrea, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Booij Jan, Kapucu L. Özlem Atay, Kluge Andreas, Ziebell Morten, Darcourt Jacques, Nobili Flavio, Pagani Marco, Sabri Osama, Hesse Swen, Borght Thierry Vander, van Laere Koen, Tatsch Klaus, la Fougère Christian Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes European journal of nuclear medicine and molecular imaging 2016;43 (7):1315-1322 [PubMed]
• Bahler Lonneke, Holleman Frits, Booij Jan, Hoekstra Joost B., Verberne Hein J. Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT Nuclear medicine communications 2016;37 (4):363-371 [PubMed]
• Siepel Françoise J., Dalen Ingvild, Grüner Renate, Booij Jan, Brønnick Kolbjørn S., Buter Tirza C., Aarsland Dag Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies Movement disorders 2016;31 (1):118-125 [PubMed]
• Heijtel D. F. R., Petersen E. T., Mutsaerts H. J. M. M., Bakker E., Schober P., Stevens M. F., van Berckel B. N. M., Majoie C. B. L. M., Booij J., van Osch M. J. P., van Bavel E. T., Boellaard R., Lammertsma A. A., Nederveen A. J. Quantitative agreement between [(15)O]H2O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume NMR in biomedicine 2016;29 (4):519-526 [PubMed]
• Gevonden Martin, Myin-Germeys Inez, Wichers Marieke, Booij Jan, van den Brink Wim, van Winkel Ruud, Selten Jean-Paul Reactivity to social stress in ethnic minority men Psychiatry research 2016;246:629-636 [PubMed]
• Vulink Nienke C., Planting Robin S., Figee Martijn, Booij Jan, Denys Damiaan Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder European neuropsychopharmacology 2016;26 (2):350-356 [PubMed]
• Buchert Ralph, Kluge Andreas, Tossici-Bolt Livia, Dickson John, Bronzel Marcus, Lange Catharina, Asenbaum Susanne, Booij Jan, Atay Kapucu L. Özlem, Svarer Claus, Koulibaly Pierre-Malick, Nobili Flavio, Pagani Marco, Sabri Osama, Sera Terez, Tatsch Klaus, Vander Borght Thierry, van Laere Koen, Varrone Andrea, Iida Hidehiro Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls European journal of nuclear medicine and molecular imaging 2016;43 (7):1323-1336 [PubMed]
• van der Zwaal Esther M., de Weijer Barbara A., van de Giessen Elsmarieke M., Janssen Ignace, Berends Frits J., van de Laar Arnold, Ackermans Mariette T., Fliers Eric, la Fleur Susanne E., Booij Jan, Serlie Mireille J. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss European neuropsychopharmacology 2016;26 (7):1190-1200 [PubMed]
• Bakker Geor, Chekrouni Nora, Vingerhoets Wilhelmina A. M., van Wieringen Jan-Peter, de Bruin Kora, Eersels Jos, de Jong Jan, Chahid Youssef, Bloemen Oswald J. , van Amelsvoort Thérèse A., Booij Jan The antagonist SPECT tracer 123I-iododexetimide binds preferentially to the muscarinic M1 receptor in-vivo, but is it also a potential tool to assess the occupancy of muscarinic M1 receptors by agonists? Receptors Receptors & Clinical Investigation 2016;3 (1)
• Vegting Yosta, Reneman Liesbeth, Booij Jan The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies Psychopharmacology 2016;233 (19-20):3473-3501 [PubMed]

2015

• Bongers Peggy, van de Giessen Elsmarieke, Roefs Anne, Nederkoorn Chantal, Booij Jan, van den Brink Wim, Jansen Anita Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods Health psychology 2015;34 (6):677-685 [PubMed]
• Zaaijer Eline Renee Chasing the dragon away: Personality as a protective factor and extended-release naltrexone as a treatment for heroin dependence 2015. 117p. ISBN 9789461825773. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij J., van den Brink W.; Co-supervisor: Goudriaan A. E.)
• Schrantee Anouk, Václavů Lena, Heijtel Dennis F. R., Caan Matthan W. A., Gsell Willy, Lucassen Paul J., Nederveen Aart J., Booij Jan, Reneman Liesbeth Dopaminergic system dysfunction in recreational dexamphetamine users Neuropsychopharmacology 2015;40 (5):1172-1180 [PubMed]
• Zaaijer Eline R., van Dijk Lonneke, de Bruin Kora, Goudriaan Anna E., Lammers Laureen A., Koeter Maarten W. J., van den Brink Wim, Booij Jan Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients Psychopharmacology 2015;232 (14):2597-2607 [PubMed]
• van Wieringen Jan-Peter Evaluation of potential agonist radioligands for imaging dopamine D2/3 receptors 2015. 249p. ISBN 9789461696175. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij J., Michel M. C.; Co-supervisor: Elsinga P. H.)
• Bakker Geor, Vingerhoets Wilhelmina A., van Wieringen Jan-Peter, de Bruin Kora, Eersels Jos, de Jong Jan, Chahid Youssef, Rutten Bart P., Dubois Susan, Watson Megan, Mogg Adrian J., Xiao Hongling, Crabtree Michael, Collier David A., Felder Christian C., Barth Vanessa N., Broad Lisa M., Bloemen Oswald J., van Amelsvoort Thérèse A., Booij Jan I-123-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M-1 In Vivo Journal of nuclear medicine 2015;56 (2):317-322 [PubMed]
• Hernaus D., Collip D., Kasanova Z., Winz O., Heinzel A., van Amelsvoort T., Shali S. M., Booij J., Rong Y., Piel M., Pruessner J., Mottaghy F. M., Myin-Germeys I. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder Translational psychiatry 2015;5:e547 [PubMed]
• Gevonden M. J., Myin-Germeys I., van den Brink W., van Os J., Selten J. P., Booij J. Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment Psychological medicine 2015;45 (8):1665-1674 [PubMed]
• de Kwaasteniet Bart P., Pinto Chedwa, Ruhé Henricus G., van Wingen Guido A., Booij Jan, Denys Damiaan Striatal Dopamine D-2/3 Receptor Availability in Treatment Resistant Depression (vol 9, e113612, 2014) PLoS ONE 2015;10 (8):e0135764 [PubMed]
• Zaaijer Eline R., de Bruin Kora, la Fleur Susanne E., Goudriaan Anna E., van den Brink Wim, Booij Jan Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats Journal of psychopharmacology (Oxford, England) 2015;29 (3):344-348 [PubMed]
• Shalgunov Vladimir, van Wieringen Jan-Peter, Janssen Henk M., Fransen P. Michel, Dierckx Rudi A. J. O., Michel Martin C., Booij Jan, Elsinga Philip H. Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers EJNMMI research 2015;5 (1):119 [PubMed]
• Shalgunov Vladimir, van Wieringen Jan-Peter, Janssen Henk M., Fransen P. Michel, Dierckx Rudi A. J. O., Michel Martin C., Booij Jan, Elsinga Philip H. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET Journal of nuclear medicine 2015;56 (1):133-139 [PubMed]
• Suwijn Sven R., van Boheemen Caroline J. M., de Haan Rob J., Tissingh Gerrit, Booij Jan, de Bie Rob M. A. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review EJNMMI research 2015;5:12 [PubMed]
• Gevonden Martin J. The odd one out : exploring the nature of the association between minority status and psychosis 2015. 111p. ISBN 9789090292045. [UvA Dissertations Online] Maastricht University: MHeNs School for Mental Health and Neuroscience. (Supervisors: Selten J. P., Booij J.; Co-supervisor: Germeys I.)

2014

• Heijtel D. F. R., Mutsaerts H. J. M. M., Bakker E., Schober P., Stevens M. F., Petersen E. T., van Berckel B. N. M., Majoie C. B. L. M., Booij J., van Osch M. J. P., VanBavel E., Boellaard R., Lammertsma A. A., Nederveen A. J. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with ¹⁵O H₂O positron emission tomography NeuroImage 2014;92:182-192 [PubMed]
• Booij Jan, van Loon Guus, de Bruin Kora, Voorn Pieter Acute administration of haloperidol does not influence 123I-FP-CIT binding to the dopamine transporter Journal of nuclear medicine 2014;55 (4):647-649 [PubMed]
• van Wieringen Jan-Peter, Michel Martin C., Janssen Henk M., Janssen Anton G., Elsinga Philip H., Booij Jan Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors EJNMMI research 2014;4:53 [PubMed]
• Hesse Swen, van de Giessen Elsmarieke, Zientek Franziska, Petroff David, Winter Karsten, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Darcourt Jacques, Akdemir Umit O., Knudsen Gitte M., Nobili Flavio, Pagani Marco, Vander Borght Thierry, van Laere Koen, Varrone Andrea, Tatsch Klaus, Sabri Osama, Booij Jan Association of central serotonin transporter availability and body mass index in healthy Europeans European neuropsychopharmacology 2014;24 (8):1240-1247 [PubMed]
• Koopman Karin Eva Maria Central serotonin and dopamine transporters in overeating, obesity and insulin resistanceAmsterdam: 2014. 176p. ISBN 9789090285115. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Fliers E., Booij J.; Co-supervisors: La Fleur S. E., Serlie M. J. M.)
• Booij Jan, Tijssen Marina A. J., Berendse Henk W. Clinical Applications of [123I]FP-CIT SPECT Imagingin: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Klaus L. Leenders, editors. PET and SPECT in neurology. Berlin; Heidelberg: Springer; 2014. p. 719-736, ISBN 9783642543067; 9783642543074
• Siepel Françoise J., Brønnick Kolbjørn S., Booij Jan, Ravina Bernard M., Lebedev Alexander V., Pereira Joana B., Grüner Renate, Aarsland Dag Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease Movement disorders 2014;29 (14):1802-1808 [PubMed]
• Knol Remco J. J., de Bruin Kora, Opmeer Brent, Voorn Pieter, Jonker Allert J., van Eck-Smit Berthe L. F., Booij Jan Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats Nuclear medicine and biology 2014;41 (1):90-95 [PubMed]
• Figee Martijn, de Koning Pelle, Klaassen Sanne, Vulink Nienke, Mantione Mariska, van den Munckhof Pepijn, Schuurman Richard, van Wingen Guido, van Amelsvoort Thérèse, Booij Jan, Denys Damiaan Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder Biological psychiatry 2014;75 (8):647-652 [PubMed]
• Ossenkoppele Rik, Booij Jan, Scheltens Philip, van Berckel Bart N. M. Dementia due to neurodegenerative disease: Molecular imaging findingsin: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Klaus L. Leenders, editors. PET and SPECT in neurology. Berlin; Heidelberg: Springer; 2014. p. 185-211, ISBN 9783642543067; 9783642543074
• Vriend Chris, Pattij Tommy, van der Werf Ysbrand D., Voorn Pieter, Booij Jan, Rutten Sonja, Berendse Henk W., van den Heuvel Odile A. Depression and impulse control disorders in Parkinson's disease: two sides of the same coin? Neuroscience and biobehavioral reviews 2014;38:60-71 [PubMed]
• van de Giessen Elsmarieke, Celik Funda, Schweitzer Dave H., van den Brink Wim, Booij Jan Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity Journal of psychopharmacology (Oxford, England) 2014;28 (9):866-873 [PubMed]
• Crunelle Cleo L., van den Brink Wim, Dom Geert, Booij Jan Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD British journal of psychiatry 2014;204 (6):486-487 [PubMed]
• Koch Walter, Unterrainer Marcus, Xiong Guoming, Bartenstein Peter, Diemling Markus, Varrone Andrea, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Booij Jan, Kapucu Ozlem L., Kluge Andreas, Ziebell Morten, Darcourt Jacques, Nobili Flavio, Pagani Marco, Hesse Swen, Vander Borght Thierry, van Laere Koen, Tatsch Klaus, la Fougère Christian Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls European journal of nuclear medicine and molecular imaging 2014;41 (10):1938-1946 [PubMed]
• van Wieringen Jan-Peter, de Bruin Kora, Janssen Henk M., Fransen P. Michel, Janssen Anton G. M., van Doremalen Peter A., Michel Martin C., Elsinga Philip H., Booij Jan Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors International journal of molecular imaging 2014;2014:507012 [PubMed]
• Gevonden Martin, Booij Jan, van den Brink Wim, Heijtel Dennis, van Os Jim, Selten Jean-Paul Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia JAMA psychiatry 2014;71 (12):1364-1372 [PubMed]
• Seibyl John P., Kupsch Andreas, Booij Jan, Grosset Donald G., Costa Durval C., Hauser Robert A., Darcourt Jacques, Bajaj Nin, Walker Zuzana, Marek Kenneth, McKeith Ian, O'Brien John T., Tatsch Klaus, Tolosa Eduardo, Dierckx Rudi A., Grachev Igor D. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging Journal of nuclear medicine 2014;55 (8):1288-1296 [PubMed]
• Ruhé Henricus G., Visser Anniek K. D., Frokjaer Vibe G., Haarman Bartholomeus C. M., Klein Hans C., Booij Jan Molecular imaging of depressive disordersin: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Johan A. den Boer, editors. PET and SPECT in psychiatry. Berlin; Heidelberg: Springer; 2014. p. 93-172, ISBN 9783642403835; 9783642403842
• Sharifi Sarvi, Nederveen Aart J., Booij Jan, van Rootselaar Anne-Fleur Neuroimaging essentials in essential tremor: A systematic review NeuroImage. Clinical 2014;5:217-231 [PubMed]
• van de Giessen Elsmarieke, McIlwrick Silja, Veltman Dick, van den Brink Wim, Booij Jan Obesity an addiction? Imaging of neurotransmitter systems in obesityin: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Johan A. den Boer, editors. PET and SPECT in psychiatry. Berlin; Heidelberg: Springer; 2014. p. 641-656, ISBN 9783642403835; 9783642403842
• Ruhé Henricus G., Koster Michiel, Booij Jan, van Herk Marcel, Veltman Dick J., Schene Aart H. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder Psychiatry research 2014;221 (2):155-161 [PubMed]
• Zaaijer Eline R., Bruijel Jessica, Blanken Peter, Hendriks Vincent, Koeter Maarten W. J., Kreek Mary Jeanne, Booij Jan, Goudriaan Anna E., van Ree Jan M., van den Brink Wim Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence Drug and alcohol dependence 2014;145:101-105 [PubMed]
• Zoons Evelien, Booij Jan, de Jong Bauke, Tijssen Marina A. J. PET and SPECT imaging in dystoniain: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Klaus L. Leenders, editors. PET and SPECT in neurology. Berlin; Heidelberg: Springer; 2014. p. 667-689, ISBN 9783642543067; 9783642543074
• Zoons Evelien, Sharifi Sarvi, Booij Jan, de Jong Bauke, Tijssen Marina A. J. PET and SPECT imaging in hyperkinetic movement disordersin: Rudy A. J. O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Klaus L. Leenders, editors. PET and SPECT in neurology. Berlin; Heidelberg: Springer; 2014. p. 691-717, ISBN 9783642543067; 9783642543074
• Booij Jan, Van Wieringen Jan Peter, Van de giessen Elsmarieke, Knol Remco J.J., Finnema Sjoerd J. PET and SPECT imaging of the central dopamine system in humansin: PET and SPECT of Neurobiological Systems. Springer Berlin Heidelberg; 2014. p. 229-248, ISBN 9783642420139
• de Koning Mariken B., Bloemen Oswald J. N., van Duin Esther D. A., Booij Jan, Abel Kathryn M., de Haan Lieuwe, Linszen Don H., van Amelsvoort Thérèse A. M. J. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis Journal of psychopharmacology (Oxford, England) 2014;28 (6):553-560 [PubMed]
• Vriend Chris, Nordbeck Anna H., Booij Jan, van der Werf Ysbrand D., Pattij Tommy, Voorn Pieter, Raijmakers Pieter, Foncke Elisabeth M. J., van de Giessen Elsmarieke, Berendse Henk W., van den Heuvel Odile A. Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease Movement disorders 2014;29 (7):904-911 [PubMed]
• Suwijn S. R., Berendse H. W., Verschuur C. V. M., de Bie R. M. A., Booij J. Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy ISRN Neurology 2014;2014:345132 [PubMed]
• de Kwaasteniet Bart P., Pinto Chedwa, Ruhé Henricus G., Ruhé Eric H. G., van Wingen Guido A., Booij Jan, Denys Damiaan Striatal dopamine D2/3 receptor availability in treatment resistant depression PLoS ONE 2014;9 (11):e113612 [PubMed]
• de Weijer Barbara A., van de Giessen Elsmarieke, Janssen Ignace, Berends Frits J., van de Laar Arnold, Ackermans Mariette T., Fliers Eric, la Fleur Susanne E., Booij Jan, Serlie Mireille J. Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity Diabetologia 2014;57 (5):1078-1080 [PubMed]
• van Wieringen Jan-Peter, Shalgunov Vladimir, Janssen Henk M., Fransen P. Michel, Janssen Anton G. M., Michel Martin C., Booij Jan, Elsinga Philip H. Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D₂/₃ receptors in their high-affinity state Journal of medicinal chemistry 2014;57 (2):391-410 [PubMed]
• Verschure Derk O., Somsen G. Aernout, van Eck-Smit Berthe L. F., Knol Remco J. J., Booij Jan, Verberne Hein J. Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of (123)I-MIBG imaging Journal of nuclear cardiology 2014;21 (4):730-738 [PubMed]
• Bernsen Monique R., Vaissier Pieter E. B., van Holen Roel, Booij Jan, Beekman Freek J., de Jong Marion The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI European journal of nuclear medicine and molecular imaging 2014;41 (1):S36-S49 [PubMed]
• Suwijn Sven R., de Bruin Kora, de Bie Rob M. A., Booij Jan The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease Parkinsonism & related disorders 2014;20 (Suppl. 1):S184-S186 [PubMed]

2013

• Siepel Françoise J., Rongve Arvid, Buter Tirza C., Beyer Mona K., Ballard Clive G., Booij Jan, Aarsland Dag (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study BMJ open 2013;3 (4):e002642 [PubMed]
• van Wieringen Jan-Peter, Booij Jan, Shalgunov Vladimir, Elsinga Philip, Michel Martin C. Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications Naunyn-Schmiedeberg s archives of pharmacology 2013;386 (2):135-154 [PubMed]
• Booij Jan, Arbizu Javier, Darcourt Jacques, Hesse Swen, Nobili Flavio, Payoux Pierre, Pappatà Sabina, Tatsch Klaus, Walker Zuzana, Pagani Marco Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine European journal of nuclear medicine and molecular imaging 2013;40 (7):1122-1125 [PubMed]
• Nobili Flavio, Naseri Mehrdad, de Carli Fabrizio, Asenbaum Susan, Booij Jan, Darcourt Jacques, Ell Peter, Kapucu Ozlem, Kemp Paul, Svarer Claus, Varer Claus, Morbelli Silvia, Pagani Marco, Sabri Osama, Tatsch Klaus, Tossici-Bolt Livia, Sera Terez, Vander Borght Tierry, van Laere Koen, Varrone Andrea Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database European journal of nuclear medicine and molecular imaging 2013;40 (4):565-573 [PubMed]
• Crunelle Cleo L., van de Giessen Elsmarieke, Schulz Sybille, Vanderschuren Louk J. M. J., de Bruin Kora, van den Brink Wim, Booij Jan Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability Addiction biology 2013;18 (6):908-911 [PubMed]
• Booij Jan, van de Giessen Elsmarieke, Hesse Swen, Sabri Osama Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects European journal of nuclear medicine and molecular imaging 2013;40 (1):143-144 [PubMed]
• Koopman Karin Eva, Booij Jan, Fliers Eric, Serlie Mireille Johanna, la Fleur Susanne Eva Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region Molecular metabolism 2013;2 (4):417-422 [PubMed]
• Nobili Flavio, Naseri Mehrdad, de Carli Fabrizio, Asenbaum Susan, Booij Jan, Darcourt Jacques, Ell Peter, Kapucu Ozlem, Kemp Paul, Svarer Claus, Morbelli Silvia, Pagani Marco, Sabri Osama, Tatsch Klaus, Tossici-Bolt Livia, Sera Terez, Borght Tierry Vander, van Laere Koen, Varrone Andrea Erratum to: Automatic semi-quantification of [(123)I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database European journal of nuclear medicine and molecular imaging 2013;40 (4):640-641
• Varrone Andrea, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Booij Jan, Kapucu Ozlem L., Kluge Andreas, Knudsen Gitte M., Koulibaly Pierre Malick, Nobili Flavio, Pagani Marco, Sabri Osama, Vander Borght Thierry, van Laere Koen, Tatsch Klaus European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis European journal of nuclear medicine and molecular imaging 2013;40 (2):213-227 [PubMed]
• van de Giessen E., La Fleur S. E., Eggels L., de Bruin K., van den Brink W., Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity International journal of obesity (2005) 2013;37 (5):754-757 [PubMed]
• Borgers Anke J., Alkemade Anneke, van de Giessen Elsmarieke M., Drent Madeleine L., Booij Jan, Bisschop Peter H., Fliers Eric Imaging of serotonin transporters with [I-123]FP-CIT SPECT in the human hypothalamus EJNMMI research 2013;3 (1):UNSP 34 [PubMed]
• Crunelle Cleo L., Veltman Dick J., van Emmerik-van Oortmerssen Katelijne, Booij Jan, van den Brink Wim Impulsivity in adult ADHD patients with and without cocaine dependence Drug and alcohol dependence 2013;129 (1-2):18-24 [PubMed]
• Booij Jan, Reneman Liesbeth, Alders Marielle, Kuijpers Taco W. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype American journal of medical genetics. Part A 2013;161A (1):102-107 [PubMed]
• Crunelle Cleo L., van den Brink Wim, Veltman Dick J., van Emmerik-van Oortmerssen Katelijne, Dom Geert, Schoevers Robert A., Booij Jan Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence European neuropsychopharmacology 2013;23 (12):1714-1723 [PubMed]
• Schouw M. L. J., Kaag A. M., Caan M. W. A., Heijtel D. F. R., Majoie C. B. L. M., Nederveen A. J., Booij J., Reneman L. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI NeuroImage 2013;72:1-9 [PubMed]
• Schouw M. L. J., Caan M. W. A., Geurts H. M., Schmand B., Booij J., Nederveen A. J., Reneman L. Monoaminergic dysfunction in recreational users of dexamphetamine European neuropsychopharmacology 2013;23 (11):1491-1502 [PubMed]
• van de Giessen Elsmarieke, Hesse Swen, Caan Matthan W. A., Zientek Franziska, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Guignard Renaud, Akdemir Umit O., Knudsen Gitte M., Nobili Flavio, Pagani Marco, Vander Borght Thierry, van Laere Koen, Varrone Andrea, Tatsch Klaus, Booij Jan, Sabri Osama No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers NeuroImage 2013;64:61-67 [PubMed]
• Thomsen Gerda, Knudsen Gitte Moos, Jensen Peter S., Ziebell Morten, Holst Klaus K., Asenbaum Susanne, Booij Jan, Darcourt Jacques, Dickson John C., Kapucu Ozlem L., Nobili Flavio, Sabri Osama, Sera Terez, Tatsch Klaus, Tossici-Bolt Livia, van Laere Koen, Borght Thierry Vander, Varrone Andrea, Pagani Marco, Pinborg Lars Hageman No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [I-123]FP-CIT (DaTSCAN) and SPECT EJNMMI research 2013;3 (1):UNSP 39 [PubMed]
• van Wingen Guido A., van den Brink Wim, Veltman Dick J., Schmaal Lianne, Dom Geert, Booij Jan, Crunelle Cleo L. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence Drug and alcohol dependence 2013;131 (3):198-203 [PubMed]
• Suwijn Sven R., Berendse Henk W., Verschuur Constant V. M., Winogrodzka Ania, de Bie Rob M. A., Booij Jan SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias EJNMMI research 2013;3 (1):UNSP 44 [PubMed]
• Bloemen Oswald J. N., de Koning Mariken B., Gleich Tobias, Meijer Julia, de Haan Lieuwe, Linszen Don H., Booij Jan, van Amelsvoort Thérèse A. M. J. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis European neuropsychopharmacology 2013;23 (2):126-132 [PubMed]
• de Koning M. Studying biomarkers in populations at genetic and clinical high risk for psychosis 2013. 200p. [UvA Dissertations Online] Maastricht University: Medicine. (Supervisors: van Amelsvoort T. A. M. J., Booij J.)
• Söderlund Therese A., Dickson John C., Prvulovich Elizabeth, Ben-Haim Simona, Kemp Paul, Booij Jan, Nobili Flavio, Thomsen Gerda, Sabri Osama, Koulibaly Pierre-Malik, Akdemir Ozgur U., Pagani Marco, van Laere Koen, Asenbaum-Nan Susanne, George Jean, Sera Terez, Tatsch Klaus, Bomanji Jamshed Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies Journal of nuclear medicine 2013;54 (5):714-722 [PubMed]
• Goorden Marlies C., van der Have Frans, Kreuger Rob, Ramakers Ruud M., Vastenhouw Brendan, Burbach J. Peter H., Booij Jan, Molthoff Carla F. M., Beekman Freek J. VECTor: a preclinical imaging system for simultaneous submillimeter SPECT and PET Journal of nuclear medicine 2013;54 (2):306-312 [PubMed]

2012

• Bouet Valentine, Klomp Anne, Freret Thomas, Wylezinska-Arridge Marzena, Lopez-Tremoleda Jordi, Dauphin François, Boulouard Michel, Booij Jan, Gsell Willy, Reneman Liesbeth Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment Psychopharmacology 2012;221 (2):329-339 [PubMed]
• Koopman Karin E., la Fleur Susanne E., Fliers Eric, Serlie Mireille J., Booij Jan Assessing the Optimal Time Point for the Measurement of Extrastriatal Serotonin Transporter Binding with I-123-FP-CIT SPECT in Healthy, Male Subjects Journal of nuclear medicine 2012;53 (7):1087-1090 [PubMed]
• van de Giessen Elsmarieke, Nimgaonkar Vishwajit L., Watson Annie M., Kodavali Chowdari, Baas Frank, Tanck Michael W. T., de Win Maartje M. L., van den Brink Wim, Booij Jan Association Tests of Striatal DAT Availability and SNPs That Impact a Novel Splice Variant in the DAT Gene Journal of nuclear medicine 2012;53 (5):839 [PubMed]
• Walker Zuzana, McKeith Ian, Rodda Joanne, Qassem Tarik, Tatsch Klaus, Booij Jan, Darcourt Jacques, O'Brien John Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study BMJ open 2012;2 (1):e000380 [PubMed]
• Beukers R. J., Contarino M. F., Speelman J. D., Schuurman P. R., Booij J., Tijssen Marina A. J. Deep Brain Stimulation of the Pallidum is Effective and Might Stabilize Striatal D(2) Receptor Binding in Myoclonus-Dystonia Frontiers in neurology 2012;3:22 [PubMed]
• Crunelle Cleo L. Development of new neurobiological strategies to treat patients with cocaine dependence 2012. 167p. ISBN 9789088914171. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij J., van den Brink W.)
• Morgan Shirlony, Kemp Paul, Booij Jan, Costa Durval C., Padayachee Shalandran, Lee Lean, Barber Christopher, Carter Janet, Walker Zuzana Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT Journal of neurology, neurosurgery, and psychiatry 2012;83 (11):1063-1070 [PubMed]
• van de Giessen Elsmarieke, la Fleur Susanne E., de Bruin Kora, van den Brink Wim, Booij Jan Free-Choice and No-Choice High-Fat Diets Affect Striatal Dopamine D-2/3 Receptor Availability, Caloric Intake, and Adiposity Obesity (Silver Spring, Md.) 2012;20 (8):1738-1740 [PubMed]
• Booij Jan, van Amelsvoort Thérèse Imaging as tool to investigate psychoses and antipsychotics Handbook of experimental pharmacology 2012;212 (212):299-337 [PubMed]
• Reneman L., de Win M. M. L., Booij J., van den Brink W., den Heeten G. J., Freling N., Majoie C. B. L. M. Incidental Head and Neck Findings on MRI in Young Healthy Volunteers: Prevalence and Clinical Implications AJNR. American journal of neuroradiology 2012;33 (10):1971-1974 [PubMed]
• Al Hussainy Rana Iodine-123 and flurine-18 radiolabeled analogues of WAY-100635 as potential radioligands for imaging the 5-HT1A receptor in the brain 2012. 150p. [UvA Dissertations Online] Vrije Universiteit Amsterdam: faculteit Geneeskunde. (Supervisors: van Dongen G. A. M. S., Booij J.; Co-supervisor: Herscheid J. D. M.)
• Schouw M. L. J., Gevers S., Caan M. W. A., Majoie C. B. L. M., Booij J., Nederveen A. J., Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI European neuropsychopharmacology 2012;22 (8):537-545 [PubMed]
• van de Giessen Elsmarieke Neurobiological aspects of obesity: dopamine, srotonin, and imaging 2012. 302p. ISBN 9789461821706. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Booij J., van den Brink W.; Co-supervisors: Baas F., La Fleur S. E.)
• Dickson John Caddell, Tossici-Bolt Livia, Sera Terez, de Nijs Robin, Booij Jan, Bagnara Maria Claudia, Seese Anita, Koulibaly Pierre Malick, Akdemir Umit Ozgur, Jonsson Cathrine, Koole Michel, Raith Maria, Lonsdale Markus Nowak, George Jean, Zito Felicia, Tatsch Klaus Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European I-123-FP-CIT SPECT database European journal of nuclear medicine and molecular imaging 2012;39 (1):188-197 [PubMed]
• Djang David S. W., Janssen Marcel J. R., Bohnen Nicolaas, Booij Jan, Henderson Theodore A., Herholz Karl, Minoshima Satoshi, Rowe Christopher C., Sabri Osama, Seibyl John, van Berckel Bart N. M., Wanner Michele SNM Practice Guideline for Dopamine Transporter Imaging with I-123-Ioflupane SPECT 1.0 Journal of nuclear medicine 2012;53 (1):154-163 [PubMed]
• Crunelle Cleo L., Veltman Dick J., Booij Jan, Emmerik-van Oortmerssen Katelijne, den Brink Wim Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research Brain and behavior 2012;2 (4):499-523 [PubMed]
• Ruhé Henricus G., Booij Jan, Veltman Dick J., Michel Martin C., Schene Aart H. Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study Journal of clinical psychiatry 2012;73 (4):451-459 [PubMed]
• Al Hussainy Rana, Verbeek Joost, van der Born Dion, Molthoff Carla, Booij Jan, Herscheid J. Koos D. M. Synthesis, biodistribution and PET studies in rats of F-18-Labeled bridgehead fluoromethyl analogues of WAY-100635 Nuclear medicine and biology 2012;39 (7):1068-1076 [PubMed]
• Braak Breg, Booij Jan, Klooker Tamira K., van den Wijngaard Rene M. J., Boeckxstaens Guy E. E. The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test European journal of nuclear medicine and molecular imaging 2012;39 (4):642-650 [PubMed]
• Klomp Anne, den Hollander Bjørnar, de Bruin Kora, Booij Jan, Reneman Liesbeth The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals PLoS ONE 2012;7 (10):e47524 [PubMed]
• Booij J., Teune L. K., Verberne H. J. The role of molecular imaging in the differential diagnosis of parkinsonism quarterly journal of nuclear medicine and molecular imaging 2012;56 (1):17-26 [PubMed]
• van de Giessen Elsmarieke, de Bruin Kora, la Fleur Susanne E., van den Brink Wim, Booij Jan Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats European neuropsychopharmacology 2012;22 (4):290-299 [PubMed]
• Crunelle Cleo L., de Wit Tim C., de Bruin Kora, Ramakers Ruud M., van der Have Frans, Beekman Freek J., van den Brink Wim, Booij Jan Varenicline increases in vivo striatal dopamine D-2/3 receptor binding: an ultra-high-resolution pinhole [I-123]IBZM SPECT study in rats Nuclear medicine and biology 2012;39 (5):640-644 [PubMed]

2011

• Bloemen Oswald J. N. Brain markers of psychosis and autism 2011. 191p. ISBN 9789090259338. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Linszen D. H., Booij J.; Co-supervisor: van Amelsvoort T. A. M. J.)
• Boot Erik, Booij Jan, Zinkstok Janneke R., Baas Frank, Swillen Ann, Owen Michael J., Murphy Declan G., Murphy Kieran C., Linszen Don H., van Amelsvoort Thérèse A. COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome Synapse (New York, N.Y.) 2011;65 (9):967-970 [PubMed]
• Al Hussainy Rana, Verbeek Joost, van der Born Dion, Booij Jan, Herscheid J. Koos D. M. Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor European journal of medicinal chemistry 2011;46 (12):5728-5735 [PubMed]
• Al Hussainy Rana, Verbeek Joost, van der Born Dion, Braker Anton H., Leysen Josée E., Knol Remco J., Booij Jan, Herscheid J. Koos D. M. Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor Journal of medicinal chemistry 2011;54 (10):3480-3491 [PubMed]
• Boot Erik, Booij Jan, Abeling Nico, Meijer Julia, da Silva Alves Fabiana, Zinkstok Janneke, Baas Frank, Linszen Don, van Amelsvoort Thérèse Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology Journal of psychopharmacology (Oxford, England) 2011;25 (7):888-895 [PubMed]
• Crunelle C. L., Schulz S., de Bruin K., Miller M. L., van den Brink W., Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats European neuropsychopharmacology 2011;21 (2):205-210 [PubMed]
• Auning Eirik, Rongve Arvid, Fladby Tormod, Booij Jan, Hortobágyi Tibor, Siepel Françoise J., Ballard Clive, Aarsland Dag Early and presenting symptoms of dementia with lewy bodies Dementia and geriatric cognitive disorders 2011;32 (3):202-208 [PubMed]
• van de Giessen E., Groot P. F. C., Booij J., van den Brink W., Veltman D. J., Nederveen A. J. Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging AJNR. American journal of neuroradiology 2011;32 (5):903-907 [PubMed]
• Bloemen Oswald J. N., Gleich Tobias, de Koning Mariken B., da Silva Alvis Fabiana, de Haan Lieuwe, Linszen Don H., Booij Jan, van Amelsvoort Thérèse A. M. J. Hippocampal glutamate levels and striatal dopamine D(2/3) receptor occupancy in subjects at ultra high risk of psychosis Biological psychiatry 2011;70 (1):e1-2; author reply e3 [PubMed]
• de Weijer Barbara A., van de Giessen Elsmarieke, van Amelsvoort Therese A., Boot Erik, Braak Breg, Janssen Ignace M., van de Laar Arnold, Fliers Eric, Serlie Mireille J., Booij Jan Lower striatal dopamine D-2/3 receptor availability in obese compared with non-obese subjects EJNMMI research 2011;1 (1):37 [PubMed]
• Booij Jan, Berendse Henk W. Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway Journal of the neurological sciences 2011;310 (1-2):40-43 [PubMed]
• Ruhé H. G., Booij J., Schene A. H. Onvoldoende response op een standaarddosering van een SSRI bij unipoliare depressie: dosisverhoging? Psyfar : Praktische nascholing over pscyhofarmacologie 2011;6 (1):19-23
• Burke S. M., van de Giessen E., de Win M., Schilt T., van Herk M., van den Brink W., Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects Psychological medicine 2011;41 (2):419-429 [PubMed]
• Zoons E., Booij J., Nederveen A. J., Dijk J. M., Tijssen M. A. J. Structural, functional and molecular imaging of the brain in primary focal dystonia-A review NeuroImage 2011;56 (3):1011-1020 [PubMed]
• Knol Remco J. J., van den Bos Jan C., Janssen Anton G. M., de Bruin Kora, van Eck-Smit Berthe L. F., Booij Jan Synthesis and In Vitro Evaluation of Novel Nortropane Derivatives as Potential Radiotracers for Muscarinic M(2) Receptors International journal of molecular imaging 2011;2011:709416 [PubMed]
• Booij Jan, Boot Erik, van Eeden Susanne, van Amelsvoort Thérèse Unexpected Detection of Nodular Melanoma of the Skin on the Scalp by I-123 IBZM Brain SPECT Clinical nuclear medicine 2011;36 (2):148-149 [PubMed]
• Ruhé H. G., Booij J., Schene A. H. Wat te doen als de eerste pil niet werkt: dosisverhoging of toch liever switchen? Psyfar : Praktische nascholing over pscyhofarmacologie 2011;6 (1):24-27

2010

• Boot Erik H. J. G. 22q11 Deletion syndrome and neurotransmitter systems in unchallenged and chalenged conditions 2010. 175p. ISBN 9789090254487. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Linszen D. H., Booij J.; Co-supervisor: van Amelsvoort T. A. M. J.)
• Rube H. G., Booij J., van Weert H. C., Reitsma J. B., Franssen E. J., Michel M. C., Schene A. H. Antwoord aan Moleman Tijdschrift voor psychiatrie 2010;52 (11):802-804
• Booij Jan, van Amelsvoort Thérèse, Boot Erik Co-Occurrence of Early-Onset Parkinson Disease and 22q11.2 Deletion Syndrome: Potential Role for Dopamine Transporter Imaging American journal of medical genetics. Part A 2010;152A (11):2937-2938 [PubMed]
• Ruhé H. G., Booij J., van Weert H. C., Reitsma J. B., Franssen E. J., Michel M. C., Schene A. Dosisverhoging van SSRI'S bij depressie; niet aan te bevelen in richtlijnen Tijdschrift voor psychiatrie 2010;52 (9):615-625 [PubMed]
• van Laere Koen, Varrone Andrea, Booij Jan, Vander Borght Thierry, Nobili Flavio, Kapucu Ozlem L., Walker Zuzana, Någren Kjell, Tatsch Klaus, Darcourt Jacques EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2 European journal of nuclear medicine and molecular imaging 2010;37 (2):434-442 [PubMed]
• Darcourt Jacques, Booij Jan, Tatsch Klaus, Varrone Andrea, Vander Borght Thierry, Kapucu Ozlem L., Någren Kjell, Nobili Flavio, Walker Zuzana, van Laere Koen EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2 European journal of nuclear medicine and molecular imaging 2010;37 (2):443-450 [PubMed]
• Veltman D. J., Ruhé H. G., Booij J. Investigating Serotonergic Function Using Positron Emission Tomography: Overview and Recent Findings Current pharmaceutical design 2010;16 (18):1979-1989 [PubMed]
• Figee M., Booij J., Denys D. Molecular imaging of Obsessive compulsive disorderin: Martha Shenton, Bruce Turetsky, editors. Understandig Neuropsychiatric Disorders: Insights from Neuroimaging. S.l.: Cambridge University Press; 2010., ISBN 9780521899420
• Ponsen Mirthe M., Stoffers Diederick, Wolters Erik Ch, Booij Jan, Berendse Henk W. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease Journal of neurology, neurosurgery, and psychiatry 2010;81 (4):396-399 [PubMed]
• Booij J., Arkies Hester Primaire progressieve afasie Tijdschrift voor nucleaire geneeskunde 2010;32 (2):514-515
• Minnee R. C., Bemelman W. A., Donselaar-van der Pant K. A. M. I., Booij J., ter Meulen S., ten Berge I. J. M., Legemate D. A., Bemelman F. J., Idu M. M. Risk Factors for Delayed Graft Function After Hand-Assisted Laparoscopic Donor Nephrectomy Transplantation proceedings 2010;42 (7):2422-2426 [PubMed]
• Boot E., Booij J., Zinkstok J. R., de Haan L., Linszen D. H., Baas F., van Amelsvoort T. A. Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study Journal of psychopharmacology (Oxford, England) 2010;24 (10):1525-1531 [PubMed]
• Crunelle Cleo L., Miller Michelle L., Booij Jan, van den Brink Wim The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review European neuropsychopharmacology 2010;20 (2):69-79 [PubMed]
• van de Giessen Elsmarieke, Booij Jan The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men European journal of nuclear medicine and molecular imaging 2010;37 (8):1507-1511 [PubMed]

2009

• Beekman Frederik Johannes, Vastenhouw Brendan, van der Wilt Gijs, Vervloet Marcia, Visscher Renee, Booij Jan, Gerrits Mirjam, Ji Changguo, Ramakers Ruud, van der Have Frans 3-D Rat Brain Phantom for High-Resolution Molecular Imaging PROCEEDINGS OF THE IEEE 2009;97 (12):1997-2005
• Dimou E., Booij J., Rodrigues M., Prosch H., Attems J., Knoll P., Zajicek B., Dudczak R., Mostbeck G., Kuntner C., Langer O., Bruecke T., Mirzaei S. Amyloid PET and MRI in Alzheimer's Disease and Mild Cognitive Impairment Current Alzheimer research 2009;6 (3):312-319 [PubMed]
• O'Brien John T., McKeith Ian G., Walker Zuzana, Tatsch Klaus, Booij Jan, Darcourt Jacques, Marquardt Moritz, Reininger Cornelia Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies British journal of psychiatry 2009;194 (1):34-39 [PubMed]
• Ruhé E., Booij J., van Weert H., Reitsma J., Fransen E., Michel M., Schene A. Dosisverhoging SSRI's bij depressie is niet zinvol Huisarts en wetenschap 2009;6 (52):289-296
• Kapucu Ozlem L., Nobili Flavio, Varrone Andrea, Booij Jan, Vander Borght Thierry, Någren Kjell, Darcourt Jacques, Tatsch Klaus, van Laere Koen J. EANM procedure guideline for brain perfusion SPECT using (99m)Tc-labelled radiopharmaceuticals, version 2 European journal of nuclear medicine and molecular imaging 2009;36 (12):2093-2102 [PubMed]
• Varrone Andrea, Asenbaum Susanne, Vander Borght Thierry, Booij Jan, Nobili Flavio, Någren Kjell, Darcourt Jacques, Kapucu Ozlem L., Tatsch Klaus, Bartenstein Peter, van Laere Koen EANM procedure guidelines for PET brain imaging using [(18)F]FDG, version 2 European journal of nuclear medicine and molecular imaging 2009;36 (12):2103-2110 [PubMed]
• Ruhé Henricus G., Booij Jan, Weert Henk C. V., Reitsma Johannes B., Fransen Eric J. F., Michel Martin C., Schene Aart H. Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy Neuropsychopharmacology 2009;34 (4):999-1010 [PubMed]
• Knol Remco J. J., de Bruin Kora, van Eck-Smit Berthe L. F., Pimlott Sally, Wyper David J., Booij Jan In vivo [(123)I]CNS-1261 binding to D-serine-activated and MK801-blocked NMDA receptors: A storage phosphor imaging study in rats Synapse (New York, N.Y.) 2009;63 (7):557-564 [PubMed]
• Zijlstra Fleur, Veltman Dick J., Booij Jan, van den Brink Wim, Franken Ingmar H. A. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males Drug and alcohol dependence 2009;99 (1-3):183-192 [PubMed]
• Marshall Vicky L., Reininger Cornelia B., Marquardt Moritz, Patterson Jim, Hadley Donald M., Oertel Wolfgang H., Benamer Hani T. S., Kemp Paul, Burn David, Tolosa Eduardo, Kulisevsky Jamie, Cunha Luis, Costa Durval, Booij Jan, Tatsch Klaus, Chaudhuri K. Ray, Ulm Gudrun, Pogarell Oliver, Höffken Helmut, Gerstner Anja, Grosset Donald G. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT Movement disorders 2009;24 (4):500-508 [PubMed]
• Beukers R. J., Booij J., Weisscher N., Zijlstra Fleur, van Amelsvoort T. A. M. J., Tijssen M. A. J. Reduced striatal D-2 receptor binding in myoclonus-dystonia European journal of nuclear medicine and molecular imaging 2009;36 (2):269-274 [PubMed]
• Ruhé Henricus G., Booij Jan, Reitsma Johannes B., Schene Aart H. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender European journal of nuclear medicine and molecular imaging 2009;36 (5):841-849 [PubMed]
• Ruhé Henricus G., Ooteman Wendy, Booij Jan, Michel Martin C., Moeton Martina, Baas Frank, Schene Aart H. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder Pharmacogenetics and genomics 2009;19 (1):67-76 [PubMed]
• van de Giessen Elisabeth M., de Win Maartje M. L., Tanck Michael W. T., van den Brink Wim, Baas Frank, Booij Jan Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3 Journal of nuclear medicine 2009;50 (1):45-52 [PubMed]
• Crunelle Cleo L., Miller Michelle L., de Bruin Kora, van den Brink Wim, Booij Jan Varenicline increases striatal dopamine D(2/3) receptor binding in rats Addiction biology 2009;14 (4):500-502 [PubMed]
• Ilse Nijs I., Ingmar Franken I., Booij Jan Verslavingsmechanismen bij excessief eetgedrag en obesitasin: I. H. A. Franken, W. van den Brink, editors. Handboek verslaving. Utrecht: De Tijdstroom; 2009. p. 14-538, ISBN 9789058981400

2008

• Boot Erik, Booij Jan, Hasler Gregor, Zinkstok Janneke R., de Haan Lieuwe, Linszen Don H., van Amelsvoort Thérèse A. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures European journal of nuclear medicine and molecular imaging 2008;35 (7):1350-1356 [PubMed]
• Visser Ieke, Lavini Cristina, Booij Jan, Reneman Liesbeth, Majoie Charles, de Boer Angela G. E. M., Wekking Elizabeth M., de Joode Elisabeth A., Van der Laan Gert, van Dijk Frank J. H., Schene Aart H., den Heeten Gerard J. Cerebral impairment in chronic solvent-induced encephalopathy Annals of neurology 2008;63 (5):572-580 [PubMed]
• Boot Erik, Booij Jan, Zinkstok Janneke, Abeling Nico, de Haan Lieuwe, Baas Frank, Linszen Don, van Amelsvoort Thérèse Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome Neuropsychopharmacology 2008;33 (6):1252-1258 [PubMed]
• Booij Jan, Kemp Paul Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs European journal of nuclear medicine and molecular imaging 2008;35 (2):424-438 [PubMed]
• Ruhé Henricus G. Dose-escalation in the picture. Pharmacological and imaging studies in depression 2008. 300p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Schene A. H.; Co-supervisor: Booij J.)
• Lindauer R. J. L., Booij J., Habraken J. B. A., van Meijel E. P. M., Uylings H. B. M., Olff M., Carlier I. V. E., den Heeten G. J., van Eck-Smit B. L. F., Gersons B. P. R. Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial Psychological medicine 2008;38 (4):543-554 [PubMed]
• Knol R. J. J. Fundamental studies on radiotracers intended for receptor imaging in dementia 2008. 244p. ISBN 9789090236148. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van Eck-Smit B. L. F.; Co-supervisor: Booij J.)
• Knol Remco J. J., de Bruin Kora, de Jong Jan, van Eck-Smit Berthe L. F., Booij Jan In vitro and ex vivo storage phosphor imaging of short-living radioisotopes Journal of neuroscience methods 2008;168 (2):341-357 [PubMed]
• Caretti V., Stoffers D., Winogrodzka A., Isaias I.-U., Costantino G., Pezzoli G., Ferrarese C., Antonini A., Wolters E.-Ch., Booij J. Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [I-123]beta-CIT SPECT study Journal of neural transmission (Vienna, Austria 2008;115 (5):721-729 [PubMed]
• de Win Maartje M. L., Jager Gerry, Booij Jan, Reneman Liesbeth, Schilt Thelma, Lavini Cristina, Olabarriaga Sílvia D., Ramsey Nick F., den Heeten Gerard J., van den Brink Wim Neurotoxic effects of ecstasy on the thalamus British journal of psychiatry 2008;193 (4):289-296 [PubMed]
• Knol R. J. J., de Bruin K., van Eck-Smit B. L. F., Booij J. No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats European journal of nuclear medicine and molecular imaging 2008;35 (3):598-604 [PubMed]
• Bennink R. J., Booij J. Positieve octreoidescintigrafie bij nasopharyngeal carcinoom Tijdschrift voor nucleaire geneeskunde 2008;29 (3):49-49
• Bennink Roelof J., van der Meulen Freerk W., Freling Nicole J., Booij Jan Somatostatin receptor scintigraphy in nasopharyngeal carcinoma Clinical nuclear medicine 2008;33 (8):558-561 [PubMed]
• Jongen Cynthia, de Bruin Kora, Beekman Freek, Booij Jan SPECT imaging of D-2 dopamine receptors and endogenous dopamine release in mice European journal of nuclear medicine and molecular imaging 2008;35 (9):1692-1698 [PubMed]
• Zijlstra Fleur, Booij Jan, van den Brink Wim, Franken Ingmar H. A. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males European neuropsychopharmacology 2008;18 (4):262-270 [PubMed]
• de Win Maartje M. L., Jager Gerry, Booij Jan, Reneman Liesbeth, Schilt Thelma, Lavini Cristina, Olabarriaga Sílvia D., den Heeten Gerard J., van den Brink Wim Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users Brain 2008;131 (Part 11):2936-2945 [PubMed]

2007

• de Win Maartje M. L., Reneman Liesbeth, Jager Gerry, Vlieger Erik-Jan P., Olabarriaga Sílvia D., Lavini Cristina, Bisschops Ivo, Majoie Charles B. L. M., Booij Jan, den Heeten Gerard J., van den Brink Wim A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users Neuropsychopharmacology 2007;32 (2):458-470 [PubMed]
• Booij J., Claus J. J. DAT-imaging differentieert tussen dementie met Lewy-lichaampjes en de ziekte van Alzheimer Tijdschrift voor neuropsychiatrie & gedragsneurologie 2007;6:144-146
• Haaxma Charlotte A., Bloem Bastiaan R., Borm George F., Oyen Wim J. G., Leenders Klaus L., Eshuis Silvia, Booij Jan, Dluzen Dean E., Horstink Martin W. I. M. Gender differences in Parkinson's disease Journal of neurology, neurosurgery, and psychiatry 2007;78 (8):819-824 [PubMed]
• Vastenhouw B., van der Have F., van der Linden A. J. A., von Oerthel L., Booij J., Burbach J. P. H., Smidt M. P., Beekman F. J. Movies of dopamine transporter occupancy with ultra-high resolution focusing pinhole SPECT Molecular psychiatry 2007;12 (11):984-987 [PubMed]
• Berendse Henk W., Booij J., Leenders K. L. Neuroimaging in movement disorders: PET and SPECT [ch.32]in: E. C. Wolters, T. van Laar, Henk W. Berendse, editors. Parkinsonism and related disorders. Amsterdam: VU University Press; 2007. p. 505-521, ISBN 9789086591503
• de Win Maartje M. L. Neurotoxity of ecstacy: causality, course, and clinical relevance 2007. 335p. ISBN 9789090214924. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van den Brink Wim, den Heeten G. J.; Co-supervisors: Booij Jan, Reneman L.)
• Booij J., Berendse Henk W. Onderscheid tussen medicatie-geinduceerd parkinsonisme en de ziekte van parkinson Tijdschrift voor neuropsychiatrie & gedragsneurologie 2007;6:45-47
• Booij Jan, de Jong Jan, de Bruin Kora, Knol Remco, de Win Maartje M. L., van Eck-Smit Berthe L. F. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: A double-blind, placebo-controlled, crossover study in healthy control subjects Journal of nuclear medicine 2007;48 (3):359-366 [PubMed]
• McKeith Ian, O'Brien John, Walker Zuzana, Tatsch Klaus, Booij Jan, Darcourt Jacques, Padovani Alessandro, Giubbini Raffaele, Bonuccelli Ubaldo, Volterrani Duccio, Holmes Clive, Kemp Paul, Tabet Naji, Meyer Ines, Reininger Cornelia Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study Lancet neurology 2007;6 (4):305-313 [PubMed]
• Booij Jan, Knol Remco J. J. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease Parkinsonism & related disorders 2007;13 (Suppl. 3):S425-S428 [PubMed]

2006

• Booij Jan, de Win Maartje M. L. Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults Nuclear medicine and biology 2006;33 (2):185-191 [PubMed]
• de Win Maartje M. L., Schilt Thelma, Reneman Liesbeth, Vervaeke Hylke, Jager Gerry, Dijkink Sarah, Booij Jan, van den Brink Wim Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study Journal of psychopharmacology (Oxford, England) 2006;20 (2):226-235 [PubMed]
• Reneman Liesbeth, Schilt T., de Win Maartje M., Booij Jan, Schmand Ben, van den Brink Wim, Bakker Onno Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users Journal of psychopharmacology (Oxford, England) 2006;20 (3):389-399 [PubMed]
• Reneman Liesbeth, de Win Maartje M. L., van den Brink Wim, Booij Jan, den Heeten Gerard J. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects Journal of psychopharmacology (Oxford, England) 2006;20 (2):164-175 [PubMed]
• Verberne Hein J., de Bruin Kora, Habraken Jan B. A., Somsen G. Aernout, Eersels Jos L. H., Moet Frits, Booij Jan, van Eck-Smit Berthe L. F. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity European journal of nuclear medicine and molecular imaging 2006;33 (4):483-490 [PubMed]
• de Haan Lieuwe, Booij Jan, Lavalaye Jules, van Amelsvoort Therese, Linszen Don Occupancy of dopamine D-2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia Psychopharmacology 2006;183 (4):500-505 [PubMed]
• Booij Jan, de Bruin Kora, Gunning W. Boudewijn Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study Nuclear medicine and biology 2006;33 (3):409-411 [PubMed]
• Abeling Nico G., Duran Marinus, Bakker Henk D., Stroomer Lida, Thöny Beat, Blau Nenad, Booij Jan, Poll-The Bwee Tien Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia Molecular genetics and metabolism 2006;89 (1-2):116-120 [PubMed]

2005

• Krygowska-Wajs A., Kachergus J. M., Hulihan M. M., Farrer M. J., Searcy J. A., Booij J., Berendse H. W., Wolters E. Ch, Wszolek Z. K. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism Journal of neural transmission (Vienna, Austria 2005;112 (11):1487-1502 [PubMed]
• de Haan Lieuwe, Lavalaye Jules, Booij Jan, Linszen Don Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics American journal of psychiatry 2005;162 (8):1544-1545 [PubMed]
• Janssen A. G., Habraken J. B. A., Booij J. DaTSCAN SPECT (afbeelden van het striatum): achtergonden en praktische aspecten Tijdschrift voor nucleaire geneeskunde 2005;27 (3):103-111
• Winogrodzka A., Booij J., Wolters E. Ch Disease-related and drug-induced changes in dopamine transporter expression might undermine the reliability of imaging studies of disease progression in Parkinson's disease Parkinsonism & related disorders 2005;11 (8):475-484 [PubMed]
• Stoffers Diederick, Booij Jan, Bosscher Lisette, Winogrodzka Ania, Wolters Erik C., Berendse Henk W. Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease European journal of nuclear medicine and molecular imaging 2005;32 (6):689-695 [PubMed]
• Lindauer R. J. L. Effects of psychotherapy on the biology posttraumatic stress disorder: brain imaging and neurophysiological correlates 2005. 208p. ISBN 9789064642234. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Gersons B. P. R., den Heeten G. J.; Co-supervisors: Booij J., Carlier I. V. E., Olff M.)
• Franken I. H. A., Zijlstra C., Booij J., van den Brink W. Imaging the addicted brain: reward, craving, and cognitive processesin: R. W. Wiers, A. W. Stacy, editors. Handbook of Implicit cognition and addiction. London: Sage publications; 2005. p. 185-199
• Ponsen M. M., Stoffers D., Booij J., van Eck-Smit B. L. F., Wolters E. C., Berendse H. W. Olfaction and early detection of Parkinson's disease - Reply Annals of neurology 2005;57 (1):157-158
• Andringa Gerda, Drukarch Benjamin, Bol John G. J. M., de Bruin Kora, Sorman Karolina, Habraken Jan B. A., Booij Jan Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease NeuroImage 2005;26 (4):1150-1158 [PubMed]
• Winogrodzka Ania, Wagenaar Robert C., Booij Jan, Wolters Eric C. Rigidity and bradykinesia reduce interlimb coordination in Parkinsonian gait Archives of physical medicine and rehabilitation 2005;86 (2):183-189 [PubMed]
• de Haan Lieuwe, Booij Jan, Lavalye Jules, van Amelsvoort T., Linszen Don Subjective experiences during dopamine depletion American journal of psychiatry 2005;162 (9):1755 [PubMed]
• de Win Maartje M. L., Jager Gerry, Vervaeke Hylke K. E., Schilt Thelma, Reneman Liesbeth, Booij Jan, Verhulst Frank C., den Heeten Gerard J., Ramsey Nick F., Korf Dirk J., van den Brink Wim The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance International journal of methods in psychiatric research 2005;14 (4):167-185 [PubMed]
• Franken Ingmar H. A., Booij Jan, van den Brink Wim The role of dopamine in human addiction: From reward to motivated attention European journal of pharmacology 2005;526 (1-3):199-206 [PubMed]
• de Win Maartje M. L., Habraken Jan B. A., Reneman Liesbeth, van den Brink Wim, den Heeten Gerard J., Booij Jan Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram Neuropsychopharmacology 2005;30 (5):996-1005 [PubMed]

2004

• Lindauer Ramón J. L., Booij Jan, Habraken Jan B. A., Uylings Harry B. M., Olff Miranda, Carlier Ingrid V. E., den Heeten Gerard J., van Eck-Smit Berthe L. F., Gersons Berthold P. R. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder Biological psychiatry 2004;56 (11):853-861 [PubMed]
• Booij J., van Eck-Smit B. L. F. Dopaminetransporter- en dopamine-D2-receptorscintigrafie met SPECT bij de ziekte van Parkinsonin: A. Hovestadt, editors. Ziekte van Parkinson. Capita Selecta. S.l.: s.n.; 2004. p. 1-7
• Loonen A. J. M., Knol R. J. J., Booij J. Frontotemporale dementie Tijdschrift voor nucleaire geneeskunde 2004;26 (3):89-92
• Booij J. Guest editorial Neuroimaging Tijdschrift voor nucleaire geneeskunde 2004;26 (3):79-81
• Ponsen Mirthe M., Stoffers Diederick, Booij Jan, van Eck-Smit Berthe L. F., Wolters Erik Ch, Berendse Henk W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease Annals of neurology 2004;56 (2):173-181 [PubMed]
• de Win Maartje M. L., Reneman Liesbeth, Reitsma Johannes B., den Heeten Gerard J., Booij Jan, van den Brink Wim Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender Psychopharmacology 2004;173 (3-4):376-382 [PubMed]
• Mirzaei S., Gelpi E., Booij J., Rodrigues M., Neumann I., Zaknun J., Koehn H., Knoll P. New approaches in nuclear medicine for early diagnosis of Alzheimer's disease Current Alzheimer research 2004;1 (3):219-229 [PubMed]
• de Haan Lieuwe, Lavalaye Jules, van Bruggen Marion, van Nimwegen Lonneke, Booij Jan, van Amelsvoort Therese, Linszen Don Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications Canadian journal of psychiatry. Revue canadienne de psychiatrie 2004;49 (5):290-296 [PubMed]
• Knol Remco J. J., Doornbos Tamme, van den Bos Jan C., de Bruin Kora, Pfaffendorf Martin, Aanhaanen Wim, Janssen Anton G. M., Vekemans Joseph A. J. M., van Eck-Smit Berthe L. F., Booij Jan Synthesis and evaluation of iodinated TZTP-derivatives as potential radioligands for imaging of muscarinic M-2 receptors with SPET Nuclear medicine and biology 2004;31 (1):111-123 [PubMed]
• de Win Maartje M. L., de Jeu Rogier A. M., de Bruin Kora, Habraken Jan B. A., Reneman Liesbeth, Booij Jan, den Heeten Gerard J. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats European neuropsychopharmacology 2004;14 (3):185-189 [PubMed]

2003

• Winogrodzka A., Bergmans P., Booij J., van Royen E. A., Stoof J. C., Wolters E. C. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease Journal of neurology, neurosurgery, and psychiatry 2003;74 (3):294-298 [PubMed]
• Reneman L., Booij J., den Heeten G. J., van den Brink W. Beeldvormend onderzoek naar de mogelijke neurotoxiciteit van ecstasy (MDMA) (Hfdst 6)in: A. H. Schene, F. de Boer, T. J. Heeren, H. W. J. Henselmans, B. Sabbe, J. van Weeghel, editors. Jaarboek voor psychiatrie en psychotherapie 2003-2004. Houten/Mechelen: Bohn Stafleu Van Loghum; 2003. p. 86-102, ISBN 9789031333974
• Booij Jan, de Bruin Kora, de Win Maartje M. L., Lavini Cristina, den Heeten Gerard J., Habraken Jan B. A. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible Nuclear medicine and biology 2003;30 (6):643-649 [PubMed]
• de Haan Lieuwe, van Bruggen Marion, Lavalaye Jules, Booij Jan, Dingemans Peter M. A. J., Linszen Don Subjective experience and D-2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: A randomized, double-blind study American journal of psychiatry 2003;160 (2):303-309 [PubMed]
• Winogrodzka A., Booij J., Wolters E. C. H. The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson's disease - Reply (letter) Journal of neurology, neurosurgery, and psychiatry 2003;74 (10):1447

2002

• Reneman L., Booij J., den Heeten G. J. Beeldvormend onderzoek naar de mogelijke neurotoxiciteit van ecstacy (MDMA)in: Handboek verslaving. S.l.: s.n.; 2002.
• Reneman L., Booij J., den Heeten G. J., van den Brink W. Effects of MDMA (ecstasy) use and abstention on serotonin neurons - Reply Lancet 2002;359 (9317):1617-1618
• Booij Jan, de Bruin Kora, Habraken Jan B. A., Voorn Pieter Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography European journal of nuclear medicine and molecular imaging 2002;29 (9):1221-1224 [PubMed]
• Reneman L., Booij J., Schmand B. A., Reitsma J. B., de Wolff F. A., Gunning W. B., den Heeten G. J., van den Brink W. Korte- en langetermijneffecten van ecstacy op serotonineproducerende hersencellen en het geheugen Nederlands tijdschrift voor geneeskunde 2002;146 (47):2240-2246
• Zijlmans Jan, Booij Jan, Valk Jaap, Lees Andrew, Horstink Martin Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway Movement disorders 2002;17 (5):1086-1087 [PubMed]
• Berendse H. W., Booij J., Stoffers D., Ponsen M. M., Hijman R., Wolters E. Ch Presymptomatische detectie van de ziekte van Parkinson Tijdschrift voor gerontologie en geriatrie 2002;33 (2):70-77 [PubMed]
• Reneman Liesbeth, Endert Erik, de Bruin Kora, Lavalaye Jules, Feenstra Mathijs G., de Wolff Freek A., Booij Jan The acute and chronic effects of MDMA ("Ecstasy") on cortical 5-HT2A receptors in rat and human brain Neuropsychopharmacology 2002;26 (3):387-396 [PubMed]
• Reneman Liesbeth, Booij Jan, Lavalaye Jules, de Bruin Kora, Reitsma Johannes B., Gunning BoudewijnW, den Heeten Gerard J., van den Brink Wim Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report Psychopharmacology 2002;159 (3):335-340 [PubMed]
• Reneman Liesbeth, Booij Jan, Habraken Jan B. A., de Bruin Kora, Hatzidimitriou George, den Heeten Gerard J., Ricaurte George A. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity Synapse (New York, N.Y.) 2002;46 (3):199-205 [PubMed]

2001

• Winogrodzka A., Bergmans P., Booij J., van Royen E. A., Janssen A. G., Wolters E. C. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease Journal of neural transmission (Vienna, Austria 2001;108 (8-9):1011-1019 [PubMed]
• Reneman L., de Bruin K., Lavalaye J., Gunning W. B., Booij J. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus Synapse (New York, N.Y.) 2001;39 (3):193-200 [PubMed]
• van de Warrenburg B. P., Lammens M., Lücking C. B., Denèfle P., Wesseling P., Booij J., Praamstra P., Quinn N., Brice A., Horstink M. W. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations Neurology 2001;56 (4):555-557 [PubMed]
• Reneman L., Lavalaye J., Schmand B., de Wolff F. A., van den Brink W., den Heeten G. J., Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings Archives of general psychiatry 2001;58 (10):901-906 [PubMed]
• Lavalaye J., Sarlet A., Booij J., Linszen D. H., Reneman L., Gersons B. P., van Royen E. A. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study Psychopharmacology 2001;155 (1):107-109 [PubMed]
• Lavalaye J., Linszen D. H., Booij J., Dingemans P. M., Reneman L., Habraken J. B., Gersons B. P., van Royen E. A. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT Schizophrenia research 2001;47 (1):59-67 [PubMed]
• Reneman L., Booij J., de Bruin K., Reitsma J. B., de Wolff F. A., Gunning W. B., den Heeten G. J., van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons Lancet 2001;358 (9296):1864-1869 [PubMed]
• Habraken J. B., de Bruin K., Shehata M., Booij J., Bennink R., van Eck Smit B. L., Busemann Sokole E. Evaluation of high-resolution pinhole SPECT using a small rotating animal Journal of nuclear medicine 2001;42 (12):1863-1869 [PubMed]
• Lavalaye J., Booij J., Linszen D. H., Reneman L., van Royen E. A. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study Psychopharmacology 2001;156 (1):53-57 [PubMed]
• Booij J., Bergmans P., Winogrodzka A., Speelman J. D., Wolters E. C. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease Synapse (New York, N.Y.) 2001;39 (2):101-108 [PubMed]
• Reneman Liesbeth, Booij Jan, Majoie Charles B. L. M., van den Brink Wim, den Heeten Gerard J. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach Human psychopharmacology 2001;16 (8):579-588 [PubMed]
• Winogrodzka A., Wagenaar R. C., Bergmans P., Vellinga A., Booij J., van Royen E. A., van Emmerik R. E., Stoof J. C., Wolters E. C. Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients Movement disorders 2001;16 (6):1033-1040 [PubMed]
• Berendse H. W., Booij J., Francot C. M., Bergmans P. L., Hijman R., Stoof J. C., Wolters E. C. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell Annals of neurology 2001;50 (1):34-41 [PubMed]
• Booij J., Speelman J. D., Horstink M. W., Wolters E. C. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism European journal of nuclear medicine 2001;28 (3):266-272 [PubMed]

2000

• Lavalaye J., Knol R. J., de Bruin K., Reneman L., Janssen A. G., Booij J. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication European journal of nuclear medicine 2000;27 (3):346-349 [PubMed]
• Lavalaye J., Booij J., Reneman L., Habraken J. B., van Royen E. A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers European journal of nuclear medicine 2000;27 (7):867-869 [PubMed]
• Reneman L., Habraken J. B., Majoie C. B., Booij J., den Heeten G. J. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings AJNR. American journal of neuroradiology 2000;21 (6):1001-1007 [PubMed]
• Reneman L., Booij J., Schmand B., van den Brink W., Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission Psychopharmacology 2000;148 (3):322-324 [PubMed]
• de Haan L., Lavalaye J., Linszen D., Dingemans P. M., Booij J. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone American journal of psychiatry 2000;157 (6):1019-1020 [PubMed]

1999

• Reneman L., Booij J., Lavalaye J., de Bruin K., de Wolff F. A., Koopmans R. P., Stoof J. C., den Heeten G. J. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain Synapse (New York, N.Y.) 1999;34 (1):77-80 [PubMed]
• Lavalaye J., Linszen D. H., Booij J., Reneman L., Gersons B. P., van Royen E. A. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia Psychiatry research 1999;92 (1):33-44 [PubMed]
• Booij J., Tissingh G., Winogrodzka A., van Royen E. A. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism European journal of nuclear medicine 1999;26 (2):171-182 [PubMed]
• Stoof J. C., Winogrodzka A., van Muiswinkel F. L., Wolters E. C., Voorn P., Groenewegen H. J., Booij J., Drukarch B. Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy European journal of pharmacology 1999;375 (1-3):75-86 [PubMed]
• Booij J., Hemelaar T. G., Speelman J. D., de Bruin K., Janssen A. G., van Royen E. A. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT Journal of nuclear medicine 1999;40 (5):753-761 [PubMed]
• Habraken J. B., Booij J., Slomka P., Sokole E. B., van Royen E. A. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm Journal of nuclear medicine 1999;40 (7):1091-1097 [PubMed]

1998

• Tissingh G., Bergmans P., Booij J., Winogrodzka A., van Royen E. A., Stoof J. C., Wolters E. C. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT Journal of neurology 1998;245 (1):14-20 [PubMed]
• Booij J., Busemann Sokole E., Stabin M. G., Janssen A. G., de Bruin K., van Royen E. A. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters European journal of nuclear medicine 1998;25 (1):24-30 [PubMed]
• Booij J., Habraken J. B., Bergmans P., Tissingh G., Winogrodzka A., Wolters E. C., Janssen A. G., Stoof J. C., van Royen E. A. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease Journal of nuclear medicine 1998;39 (11):1879-1884 [PubMed]
• Booij J., Knol R. J., Reneman L., de Bruin K., Janssen A. G., van Royen E. A. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats European journal of nuclear medicine 1998;25 (12):1666-1669 [PubMed]
• Tissingh G., Booij J., Bergmans P., Winogrodzka A., Janssen A. G., van Royen E. A., Stoof J. C., Wolters E. C. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease Journal of nuclear medicine 1998;39 (7):1143-1148 [PubMed]
• Hulshof M. C., Rehmann C. J., Booij J., van Royen E. A., Bosch D. A., González González D. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study Radiotherapy and oncology 1998;48 (2):135-142 [PubMed]

1997

• Tissingh G., Bergmans P., Booij J., Winogrodzka A., Stoof J. C., Wolters E. C., van Royen E. A. [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls European journal of nuclear medicine 1997;24 (9):1171-1174 [PubMed]
• Booij J., Andringa G., Rijks L. J., Vermeulen R. J., de Bruin K., Boer G. J., Janssen A. G., van Royen E. A. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys Synapse (New York, N.Y.) 1997;27 (3):183-190 [PubMed]
• Booij J., Tissingh G., Boer G. J., Speelman J. D., Stoof J. C., Janssen A. G., Wolters E. C., van Royen E. A. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease Journal of neurology, neurosurgery, and psychiatry 1997;62 (2):133-140 [PubMed]
• Booij J., Korn P., Linszen D. H., van Royen E. A. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography European journal of nuclear medicine 1997;24 (6):674-677 [PubMed]
• Claus J. J., Dubois E. A., Booij J., Habraken J., de Munck J. C., van Herk M., Verbeeten B., van Royen E. A. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography European journal of nuclear medicine 1997;24 (6):602-608 [PubMed]
• Horstink C. A., Praamstra P., Horstink M. W., Berger H. J., Booij J., van Royen E. A. Low striatal D2 receptor binding as assessed by [123I]IBZM SPECT in patients with writer's cramp Journal of neurology, neurosurgery, and psychiatry 1997;62 (6):672-673 [PubMed]
• Tissingh G., Bergmans P., Winogrodzka A., Stoof J. C., Wolters E. C., Booij J., van Royen E. A. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET Journal of nuclear medicine 1997;38 (8):1271-1272 [PubMed]
• Booij J., Tissingh G., Winogrodzka A., Boer G. J., Stoof J. C., Wolters E. C., van Royen E. A. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease European journal of nuclear medicine 1997;24 (1):68-71 [PubMed]

1996

• Rijks L. J., Booij J., Doornbos T., Boer G. J., Ronken E., de Bruin K., Vermeulen R. J., Janssen A. G., van Royen E. A. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands Synapse (New York, N.Y.) 1996;23 (3):201-207 [PubMed]

1995

• Vermeulen R. J., Wolters E. C., Tissingh G., Booij J., Janssen A. G., Habraken J., Sokole-Busemann E., Stoof J. C., van Royen E. A. Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease Nuclear medicine and biology 1995;22 (8):985-991 [PubMed]